Review



atrx h300 antibody  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology atrx h300 antibody
    ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for <t>ATRX</t> and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.
    Atrx H300 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+gr/pmc12264150-447-7-9
    Average 90 stars, based on 1 article reviews
    atrx h300 antibody - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion"

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    Journal: The EMBO Journal

    doi: 10.1038/s44318-025-00465-6

    ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for ATRX and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.
    Figure Legend Snippet: ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for ATRX and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.

    Techniques Used: Stable Transfection, Expressing, Immunoprecipitation, Control, Western Blot, FLAG-tag

    ( A , B ) HEK-293T cells expressing Myc-Pds5B were subjected to immunoprecipitation using anti-Myc beads or control IgG, followed by mass spectrometry ( A ) or immunoblotting with antibodies against the Myc tag, ATRX, and RAD21 ( B ). ( C , D ) HEK-293T cells expressing Myc-Pds5B and/or ATRX-GFP were immunoprecipitated using anti-Myc ( C ) or anti-GFP ( D ) beads, followed by immunoblotting for the Myc tag, GFP, GAPDH, or α-Tubulin as indicated. ( E ) HeLa cells stably expressing ATRX-GFP were transfected with control or Pds5B-targeting siRNA. Forty-eight hours post-transfection, cells were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, Pds5B, SMC1A, SMC3, and RAD21. ( F – I ) HEK-293T cells co-expressing ATRX-GFP and Myc-tagged SMC1A ( F ), SMC3 ( G ), RAD21 ( H ), or SA2 ( I ) were immunoprecipitated using anti-GFP beads and immunoblotted for GFP and the Myc tag. Myc-Pds5B co-transfection was used as a positive control. .
    Figure Legend Snippet: ( A , B ) HEK-293T cells expressing Myc-Pds5B were subjected to immunoprecipitation using anti-Myc beads or control IgG, followed by mass spectrometry ( A ) or immunoblotting with antibodies against the Myc tag, ATRX, and RAD21 ( B ). ( C , D ) HEK-293T cells expressing Myc-Pds5B and/or ATRX-GFP were immunoprecipitated using anti-Myc ( C ) or anti-GFP ( D ) beads, followed by immunoblotting for the Myc tag, GFP, GAPDH, or α-Tubulin as indicated. ( E ) HeLa cells stably expressing ATRX-GFP were transfected with control or Pds5B-targeting siRNA. Forty-eight hours post-transfection, cells were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, Pds5B, SMC1A, SMC3, and RAD21. ( F – I ) HEK-293T cells co-expressing ATRX-GFP and Myc-tagged SMC1A ( F ), SMC3 ( G ), RAD21 ( H ), or SA2 ( I ) were immunoprecipitated using anti-GFP beads and immunoblotted for GFP and the Myc tag. Myc-Pds5B co-transfection was used as a positive control. .

    Techniques Used: Expressing, Immunoprecipitation, Control, Mass Spectrometry, Western Blot, Stable Transfection, Transfection, Cotransfection, Positive Control

    ( A ) HEK-293T cells co-expressing ATRX-GFP and the indicated Pds5B-Flag truncations were immunoprecipitated using anti-GFP beads and analyzed by immunoblotted for GFP, the Flag tag, and α-Tubulin. ( B ) Schematic representation of GST-Pds5B (1–300) binding to ATRX mutants. ( C – G ) Pull-down assays of the indicated ATRX-GFP truncations using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and Coomassie Brilliant Blue (CBB) staining. ( H ) HEK-293T cells expressing ATRX-GFP (WT or Y1419A) and/or Myc-Pds5B were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, the Myc tag, and α-Tubulin. ( I ) Alignment of ATRX sequences from multiple species surrounding the conserved RSYK motif. ( J ) AlphaFold3 model of the ATRX (RSYKQ) peptide bound to Pds5B (1–300). ATRX (RSYKQ) is shown as sticks, and Pds5B as an electrostatic surface. The interaction between Y1419 of ATRX and Pds5B residues F88, A92, V138, and I143 is highlighted. .
    Figure Legend Snippet: ( A ) HEK-293T cells co-expressing ATRX-GFP and the indicated Pds5B-Flag truncations were immunoprecipitated using anti-GFP beads and analyzed by immunoblotted for GFP, the Flag tag, and α-Tubulin. ( B ) Schematic representation of GST-Pds5B (1–300) binding to ATRX mutants. ( C – G ) Pull-down assays of the indicated ATRX-GFP truncations using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and Coomassie Brilliant Blue (CBB) staining. ( H ) HEK-293T cells expressing ATRX-GFP (WT or Y1419A) and/or Myc-Pds5B were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, the Myc tag, and α-Tubulin. ( I ) Alignment of ATRX sequences from multiple species surrounding the conserved RSYK motif. ( J ) AlphaFold3 model of the ATRX (RSYKQ) peptide bound to Pds5B (1–300). ATRX (RSYKQ) is shown as sticks, and Pds5B as an electrostatic surface. The interaction between Y1419 of ATRX and Pds5B residues F88, A92, V138, and I143 is highlighted. .

    Techniques Used: Expressing, Immunoprecipitation, FLAG-tag, Binding Assay, Western Blot, Staining

    ( A ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( B – E ) Recombinant GFP-ATRX (1394–1443)-2xStrep (wild-type or mutants) proteins were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( F ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down using GFP-2xStrep or GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, and CBB staining. ( G ) Cartoon presentation of the structure for ATRX (RSYKQ) binding to Pds5B (1–300). ATRX and Pds5B residues are shown in yellow and gray, respectively. The binding details of ATRX residues R1417, S1418, Y1419, K1420, and Q1421 with Pds5B residues Q47, F88, A92, V138, and I143 are depicted. ( H , I ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( J ) HEK-293T cells expressing ATRX-GFP (WT, R1417A or R1417E) were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining.
    Figure Legend Snippet: ( A ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( B – E ) Recombinant GFP-ATRX (1394–1443)-2xStrep (wild-type or mutants) proteins were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( F ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down using GFP-2xStrep or GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, and CBB staining. ( G ) Cartoon presentation of the structure for ATRX (RSYKQ) binding to Pds5B (1–300). ATRX and Pds5B residues are shown in yellow and gray, respectively. The binding details of ATRX residues R1417, S1418, Y1419, K1420, and Q1421 with Pds5B residues Q47, F88, A92, V138, and I143 are depicted. ( H , I ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( J ) HEK-293T cells expressing ATRX-GFP (WT, R1417A or R1417E) were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining.

    Techniques Used: Expressing, Western Blot, Staining, Recombinant, Binding Assay

    ( A – C ) HeLa cells were transfected with control or ATRX siRNA duplexes. Forty-eight hours post-transfection, cells were either analyzed by immunoblotting for ATRX and GAPDH ( A ) or treated with MG132 and then fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: ns p = 1.04E−01, ns p = 0.2203, * p = 4.93E−02, * p = 4.10E−02, ** p = 2.40E−03, * p = 0.018, ** p = 5.50E−03, ** p = 4.60E−03, ** p = 3.60E−03, **** p = 3.50E−05, **** p = 5.00E−06, **** p = 3.50E−05, **** p = 3.00E−06, **** p = 6.70E−05, **** p = 2.00E−06 ( B ). Representative images are shown, with arrows indicating misaligned chromosomes ( C ). ( D ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA and synchronized in early S phase with thymidine. Seven hours after thymidine release, cells were treated with STLC for 5 h. Mitotic cells were then collected and released into MG132-containing medium for live imaging of mitosis progression. The time from STLC washout to metaphase alignment and from metaphase to chromosome scattering or the imaging endpoint was recorded. See Movies and . ( E , F ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h. Mitotic cells were collected for chromosome spread preparation, stained with CENP-C antibodies and DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was determined from more than 930 cells per condition across three independent experiments. p values from left to right: ** p = 3.04E−03, *** p = 4.16E−04, ** p = 4.53E−03 ( E ). Representative images are shown ( F ). ( G , H ) HeLa cells were transfected as above, then fixed and stained with DAPI. The percentage of cells displaying lagging chromosomes was quantified from more than 490 cells per condition across three independent experiments. p values from left to right: *** p = 8.13E−04, ** p = 5.62E−03, * p = 2.54E−02 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). ( I ) HeLa cells were transfected as described above and treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 700 cells per condition across three independent experiments. p values from left to right: ** p = 2.86E−03, ** p = 4.19E−03, *** p = 4.63E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , E , G , I ). Means and standard deviations (SDs) are shown ( B , E , G , I ). ns, no significance. Scale bars, 10 µm ( C , F , H ). .
    Figure Legend Snippet: ( A – C ) HeLa cells were transfected with control or ATRX siRNA duplexes. Forty-eight hours post-transfection, cells were either analyzed by immunoblotting for ATRX and GAPDH ( A ) or treated with MG132 and then fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: ns p = 1.04E−01, ns p = 0.2203, * p = 4.93E−02, * p = 4.10E−02, ** p = 2.40E−03, * p = 0.018, ** p = 5.50E−03, ** p = 4.60E−03, ** p = 3.60E−03, **** p = 3.50E−05, **** p = 5.00E−06, **** p = 3.50E−05, **** p = 3.00E−06, **** p = 6.70E−05, **** p = 2.00E−06 ( B ). Representative images are shown, with arrows indicating misaligned chromosomes ( C ). ( D ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA and synchronized in early S phase with thymidine. Seven hours after thymidine release, cells were treated with STLC for 5 h. Mitotic cells were then collected and released into MG132-containing medium for live imaging of mitosis progression. The time from STLC washout to metaphase alignment and from metaphase to chromosome scattering or the imaging endpoint was recorded. See Movies and . ( E , F ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h. Mitotic cells were collected for chromosome spread preparation, stained with CENP-C antibodies and DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was determined from more than 930 cells per condition across three independent experiments. p values from left to right: ** p = 3.04E−03, *** p = 4.16E−04, ** p = 4.53E−03 ( E ). Representative images are shown ( F ). ( G , H ) HeLa cells were transfected as above, then fixed and stained with DAPI. The percentage of cells displaying lagging chromosomes was quantified from more than 490 cells per condition across three independent experiments. p values from left to right: *** p = 8.13E−04, ** p = 5.62E−03, * p = 2.54E−02 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). ( I ) HeLa cells were transfected as described above and treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 700 cells per condition across three independent experiments. p values from left to right: ** p = 2.86E−03, ** p = 4.19E−03, *** p = 4.63E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , E , G , I ). Means and standard deviations (SDs) are shown ( B , E , G , I ). ns, no significance. Scale bars, 10 µm ( C , F , H ). .

    Techniques Used: Transfection, Control, Western Blot, Staining, Stable Transfection, Expressing, Imaging

    ( A ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA, followed by live imaging of mitosis progression. Selected movie frames are shown. Time is indicated in hours: minutes. Arrows point to scattering chromosomes. Related to Fig. . ( B , C ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. Representative super-resolution images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( F ). Representative images are shown ( G ). ( H – L ) HeLa cells were transfected with the indicated siRNAs, co-transfected with NLS-dCas9-EGFP-expressing vector and the sgRNA-expressing vector, and synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for GFP and DAPI. Representative images are shown ( H ). The sister loci distance was measured in more than 450 cells per condition across two independent experiments, and the means and ranges are plotted ( I ). Sister loci distances from two individual experiments are shown. p values from left to right: ns p = 6.12E−01, **** p < 1.00E−15 ( J ). ns p = 3.95E−01, **** p < 1.00E−15 ( K ). Cell lysates were analyzed by immunoblotting for ATRX, Sororin, and GAPDH ( L ). Data information: Statistics were performed using unpaired Student’s t-test ( E , F , J , K ). Means and SDs are shown ( E , F , J , K ). ns, no significance. Scale bars, 10 µm ( A , B , G , H ).
    Figure Legend Snippet: ( A ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA, followed by live imaging of mitosis progression. Selected movie frames are shown. Time is indicated in hours: minutes. Arrows point to scattering chromosomes. Related to Fig. . ( B , C ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. Representative super-resolution images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( F ). Representative images are shown ( G ). ( H – L ) HeLa cells were transfected with the indicated siRNAs, co-transfected with NLS-dCas9-EGFP-expressing vector and the sgRNA-expressing vector, and synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for GFP and DAPI. Representative images are shown ( H ). The sister loci distance was measured in more than 450 cells per condition across two independent experiments, and the means and ranges are plotted ( I ). Sister loci distances from two individual experiments are shown. p values from left to right: ns p = 6.12E−01, **** p < 1.00E−15 ( J ). ns p = 3.95E−01, **** p < 1.00E−15 ( K ). Cell lysates were analyzed by immunoblotting for ATRX, Sororin, and GAPDH ( L ). Data information: Statistics were performed using unpaired Student’s t-test ( E , F , J , K ). Means and SDs are shown ( E , F , J , K ). ns, no significance. Scale bars, 10 µm ( A , B , G , H ).

    Techniques Used: Stable Transfection, Expressing, Transfection, Control, Imaging, Staining, Western Blot, Plasmid Preparation

    ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h. Mitotic cells were collected for chromosome spread preparation and subjected to immunofluorescence staining with ATRX and CENP-C antibodies, and DAPI. ( B ) HeLa and HP1α/γ DKO cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. ( C , D ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative super-resolution images are shown ( C ). The number of centromeric ATRX foci was quantified from more than 299 chromosomes per condition across two independent experiments ( D ). ( E ) HeLa cells stably expressing siRNA-resistant ATRX-GFP (WT or Y1419A) were analyzed by immunoblotting for ATRX, GFP, and GAPDH. ( F ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were arrested in mitosis with nocodazole, immunoprecipitated using anti-GFP beads, and analyzed by immunoblotting for Pds5B, HP1α, and GFP. S. exp., short exposure; L. exp., long exposure. ( G , H ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. Representative super-resolution images are shown ( G ). The number of centromeric ATRX foci was quantified from more than 46 chromosomes ( H ). Data information: Scale bars, 10 µm ( A , B , C , G ). .
    Figure Legend Snippet: ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h. Mitotic cells were collected for chromosome spread preparation and subjected to immunofluorescence staining with ATRX and CENP-C antibodies, and DAPI. ( B ) HeLa and HP1α/γ DKO cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. ( C , D ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative super-resolution images are shown ( C ). The number of centromeric ATRX foci was quantified from more than 299 chromosomes per condition across two independent experiments ( D ). ( E ) HeLa cells stably expressing siRNA-resistant ATRX-GFP (WT or Y1419A) were analyzed by immunoblotting for ATRX, GFP, and GAPDH. ( F ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were arrested in mitosis with nocodazole, immunoprecipitated using anti-GFP beads, and analyzed by immunoblotting for Pds5B, HP1α, and GFP. S. exp., short exposure; L. exp., long exposure. ( G , H ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. Representative super-resolution images are shown ( G ). The number of centromeric ATRX foci was quantified from more than 46 chromosomes ( H ). Data information: Scale bars, 10 µm ( A , B , C , G ). .

    Techniques Used: Transfection, Control, Immunofluorescence, Staining, Stable Transfection, Expressing, Western Blot, Immunoprecipitation

    ( A ) HeLa cells stably expressing Myc-Pds5B were synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for ATRX, the Myc tag, ACA, and DAPI. Representative images are shown. ( B ) HeLa cells were synchronized in G2 phase as described above and stained for ATRX, HP1α, ACA, and DAPI. Representative images are shown. ( C ) HeLa and HP1α/γ DKO cells were stained for ATRX, HP1α, CENP-C, and DAPI. Representative images are shown. ( D , E ) HeLa cells were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. The fluorescence intensity ratio of ATRX to ACA was quantified on more than 230 chromosomes from 15–20 cells. p values from left to right: ns p = 6.59E−02, ns p = 1.91E−01, ns p = 9.35E−01, ns p = 2.07E−01 ( D ). Representative images are shown ( E ). ( F – H ) HeLa cells stably expressing Sororin-GFP were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The fluorescence intensity ratio of Sororin-GFP to ACA was quantified on more than 195 chromosomes from 15 to 20 cells. p values from left to right: **** p < 1E−15, **** p < 1E−15, **** p < 1E−15, **** p < 1E−15 ( F ). Representative images are shown ( G ). Cell lysates were analyzed by immunoblotting for GFP and α-Tubulin ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( D , F ). Means and SDs are shown ( D , F ). N.S., no significance. Scale bars, 10 µm ( A , B , C , E , G ).
    Figure Legend Snippet: ( A ) HeLa cells stably expressing Myc-Pds5B were synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for ATRX, the Myc tag, ACA, and DAPI. Representative images are shown. ( B ) HeLa cells were synchronized in G2 phase as described above and stained for ATRX, HP1α, ACA, and DAPI. Representative images are shown. ( C ) HeLa and HP1α/γ DKO cells were stained for ATRX, HP1α, CENP-C, and DAPI. Representative images are shown. ( D , E ) HeLa cells were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. The fluorescence intensity ratio of ATRX to ACA was quantified on more than 230 chromosomes from 15–20 cells. p values from left to right: ns p = 6.59E−02, ns p = 1.91E−01, ns p = 9.35E−01, ns p = 2.07E−01 ( D ). Representative images are shown ( E ). ( F – H ) HeLa cells stably expressing Sororin-GFP were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The fluorescence intensity ratio of Sororin-GFP to ACA was quantified on more than 195 chromosomes from 15 to 20 cells. p values from left to right: **** p < 1E−15, **** p < 1E−15, **** p < 1E−15, **** p < 1E−15 ( F ). Representative images are shown ( G ). Cell lysates were analyzed by immunoblotting for GFP and α-Tubulin ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( D , F ). Means and SDs are shown ( D , F ). N.S., no significance. Scale bars, 10 µm ( A , B , C , E , G ).

    Techniques Used: Stable Transfection, Expressing, Staining, Fluorescence, Western Blot

    ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were analyzed by immunoblotting for ATRX, RAD21, SMC1A, SMC3, SA2, Pds5B, Sororin, Wapl, and GAPDH. ( B , C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected as described above, treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments. p values from left to right: **** p < 1.00E−15. ns p = 1.01E−01, **** p < 1.00E−15 ( B ). **** p < 1.00E−15 ( J ). ns p = 5.10E−01, **** p < 1.00E−15 ( C ). Related to Fig. . ( D , E ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were subjected to mitotic index analysis. The mitotic index was determined from more than 940 cells per condition across two independent experiments ( D ). Representative images of cells are shown, with round cells classified as mitotic ( E ). ( F ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) transfected as described above were treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: **** p = 5.30E−05. **** p = 5.00E−05, ns p = 9.92E−01, ns p = 2.09E−01. **** p = 2.44E−04. **** p = 2.29E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , C , F ). Means and SDs are shown ( B , C , F ). ns, no significance. Scale bars, 10 µm ( E ).
    Figure Legend Snippet: ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were analyzed by immunoblotting for ATRX, RAD21, SMC1A, SMC3, SA2, Pds5B, Sororin, Wapl, and GAPDH. ( B , C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected as described above, treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments. p values from left to right: **** p < 1.00E−15. ns p = 1.01E−01, **** p < 1.00E−15 ( B ). **** p < 1.00E−15 ( J ). ns p = 5.10E−01, **** p < 1.00E−15 ( C ). Related to Fig. . ( D , E ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were subjected to mitotic index analysis. The mitotic index was determined from more than 940 cells per condition across two independent experiments ( D ). Representative images of cells are shown, with round cells classified as mitotic ( E ). ( F ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) transfected as described above were treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: **** p = 5.30E−05. **** p = 5.00E−05, ns p = 9.92E−01, ns p = 2.09E−01. **** p = 2.44E−04. **** p = 2.29E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , C , F ). Means and SDs are shown ( B , C , F ). ns, no significance. Scale bars, 10 µm ( E ).

    Techniques Used: Transfection, Control, Western Blot, Stable Transfection, Expressing, Staining

    ( A – C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 500 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, *** p = 7.60E−04, ns p = 3.31E−01, ns p = 7.75E−02, *** p = 3.77E−04, **** p = 9.60E−05 ( A ). Representative images are shown ( B ). Cell lysates were immunoblotted for ATRX, GFP, and GAPDH ( C ). ( D , E ) Cells transfected with siRNAs as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments (see Fig. ). Means and ranges are plotted ( D ). Representative images are shown ( E ). ( F ) Cells transfected with siRNAs as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 620 cells per condition across three independent experiments. p values from left to right: ns p = 1.40E−01. ns p = 6.74E−02, ** p = 1.71E−03, ** p = 1.48E−03. ns p = 6.43E−02. ** p = 6.81E−03, *** p = 4.86E−04, **** p = 4.70E−05 (HeLa). ns p = 5.39E−02. * p = 1.32E−02, *** p = 6.11E−04, *** p = 5.09E−04. * p = 2.47E−02. * p = 2.26E−02, ** p = 1.60E−03, ** p = 1.30E−03 (ATRX-GFP). ns p = 1.47E−01. * p = 1.99E−02, ** p = 1.64E−03, ** p = 1.25E−03. * p = 4.43E−02. ** p = 2.78E−03, *** p = 1.38E−04, **** p = 4.25E−07 (ATRX-Y1419A-GFP). ( G , H ) Cells transfected with siRNAs as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was determined from more than 530 cells per condition across three independent experiments. p values from left to right: ** p = 1.69E−03, *** p = 1.86E−04, ns p = 5.64E−01, ns p = 2.70E−01, ** p = 1.06E−03, ** p = 1.16E−03 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( A , F , G ). Means and SDs are shown ( A , F , G ). ns, no significance. Scale bars, 10 µm ( B , E , H ). .
    Figure Legend Snippet: ( A – C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 500 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, *** p = 7.60E−04, ns p = 3.31E−01, ns p = 7.75E−02, *** p = 3.77E−04, **** p = 9.60E−05 ( A ). Representative images are shown ( B ). Cell lysates were immunoblotted for ATRX, GFP, and GAPDH ( C ). ( D , E ) Cells transfected with siRNAs as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments (see Fig. ). Means and ranges are plotted ( D ). Representative images are shown ( E ). ( F ) Cells transfected with siRNAs as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 620 cells per condition across three independent experiments. p values from left to right: ns p = 1.40E−01. ns p = 6.74E−02, ** p = 1.71E−03, ** p = 1.48E−03. ns p = 6.43E−02. ** p = 6.81E−03, *** p = 4.86E−04, **** p = 4.70E−05 (HeLa). ns p = 5.39E−02. * p = 1.32E−02, *** p = 6.11E−04, *** p = 5.09E−04. * p = 2.47E−02. * p = 2.26E−02, ** p = 1.60E−03, ** p = 1.30E−03 (ATRX-GFP). ns p = 1.47E−01. * p = 1.99E−02, ** p = 1.64E−03, ** p = 1.25E−03. * p = 4.43E−02. ** p = 2.78E−03, *** p = 1.38E−04, **** p = 4.25E−07 (ATRX-Y1419A-GFP). ( G , H ) Cells transfected with siRNAs as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was determined from more than 530 cells per condition across three independent experiments. p values from left to right: ** p = 1.69E−03, *** p = 1.86E−04, ns p = 5.64E−01, ns p = 2.70E−01, ** p = 1.06E−03, ** p = 1.16E−03 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( A , F , G ). Means and SDs are shown ( A , F , G ). ns, no significance. Scale bars, 10 µm ( B , E , H ). .

    Techniques Used: Stable Transfection, Expressing, Transfection, Control, Staining

    ( A ) HeLa cells stably expressing CB-GFP or CB-ATRX (1394–1443)-GFP (WT or Y1419A) were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin. ( B – D ) HeLa cells stably expressing the indicated proteins were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 770 cells per condition across three independent experiments. p values from left to right: *** p = 6.69E−04, ns p = 5.30E−01, ** p = 1.04E−03 ( B ). Representative images are shown ( C ). Cell lysates were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin ( D ). ( E – H ) Cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-A and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 90 cells per condition across two independent experiments, and the means and ranges are plotted ( E ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, * p = 3.62E−02, **** p = 7.27E−06 ( F ). **** p < 1.00E−15, ns p = 1.11E−01, **** p < 1.00E−15 ( G ). Representative images are shown ( H ). ( I ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes were determined from more than 670 cells per condition across three independent experiments. p values from left to right: ns p = 6.74E−02. ns p = 6.02E−02, ** p = 3.47E−03, ** p = 2.39E−03. * p = 2.21E−02. ** p = 6.22E−03, *** p = 3.34E−04, **** p = 6.14E−07 (CB-GFP). ** p = 1.20E−03. * p = 1.1E−02, ** p = 1.21E−03, ** p = 1.55E−03. * p = 4.76E−02. * p = 1.50E−02, *** p = 1.25E−04, *** p = 1.10E−04 (CB-ATRX (1394–1443)-GFP). ns p = 1.23E−01. * p = 3.33E−02, ** p = 1.15E−03, *** p = 6.70E−04. * p = 1.36E−02. ** p = 2.20E−03, **** p = 3.70E−05, **** p = 6.32E−06 (CB-ATRX (1394–1443)-GFP-Y1419A). ( J ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was quantified from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 4.40E−05, * p = 1.10E−02, **** p = 3.90E−05. Data information: Statistics were performed using unpaired Student’s t-test ( B , F , G , I , J ). Means and SDs are shown ( B , F , G , I , J ). ns, no significance. Scale bars, 10 µm ( C , H ). .
    Figure Legend Snippet: ( A ) HeLa cells stably expressing CB-GFP or CB-ATRX (1394–1443)-GFP (WT or Y1419A) were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin. ( B – D ) HeLa cells stably expressing the indicated proteins were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 770 cells per condition across three independent experiments. p values from left to right: *** p = 6.69E−04, ns p = 5.30E−01, ** p = 1.04E−03 ( B ). Representative images are shown ( C ). Cell lysates were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin ( D ). ( E – H ) Cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-A and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 90 cells per condition across two independent experiments, and the means and ranges are plotted ( E ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, * p = 3.62E−02, **** p = 7.27E−06 ( F ). **** p < 1.00E−15, ns p = 1.11E−01, **** p < 1.00E−15 ( G ). Representative images are shown ( H ). ( I ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes were determined from more than 670 cells per condition across three independent experiments. p values from left to right: ns p = 6.74E−02. ns p = 6.02E−02, ** p = 3.47E−03, ** p = 2.39E−03. * p = 2.21E−02. ** p = 6.22E−03, *** p = 3.34E−04, **** p = 6.14E−07 (CB-GFP). ** p = 1.20E−03. * p = 1.1E−02, ** p = 1.21E−03, ** p = 1.55E−03. * p = 4.76E−02. * p = 1.50E−02, *** p = 1.25E−04, *** p = 1.10E−04 (CB-ATRX (1394–1443)-GFP). ns p = 1.23E−01. * p = 3.33E−02, ** p = 1.15E−03, *** p = 6.70E−04. * p = 1.36E−02. ** p = 2.20E−03, **** p = 3.70E−05, **** p = 6.32E−06 (CB-ATRX (1394–1443)-GFP-Y1419A). ( J ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was quantified from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 4.40E−05, * p = 1.10E−02, **** p = 3.90E−05. Data information: Statistics were performed using unpaired Student’s t-test ( B , F , G , I , J ). Means and SDs are shown ( B , F , G , I , J ). ns, no significance. Scale bars, 10 µm ( C , H ). .

    Techniques Used: Stable Transfection, Expressing, Western Blot, Transfection, Control, Staining

    ( A – C ) HeLa cells were transfected with control siRNA, ATRX siRNA, and/or Wapl siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from 1000 cells per condition across three independent experiments. p values from left to right: *** p = 1.05E−04, * p = 4.10E−02 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX, Wapl, and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, ns p = 8.92E−02 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, ns p = 4.73E−02 ( F ). Representative images are shown ( G ). ( H, I ) HeLa cells transfected as described above were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative images are shown ( H ). Cell lysates were analyzed by immunoblotting for Wapl and α-Tubulin ( I ). ( J ) HeLa cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 700 cells per condition across three independent experiments. p values from left to right: * p = 2.73E−02, ns p = 3.80E−01, ns p = 9.86E−01, ** p = 2.36E−03, ns p = 7.80E−01, ns p = 4.34E−01, *** p = 1.85E−04, ns p = 7.17E−02, ns p = 3.57E−01, *** p = 1.21E−04, ns p = 6.58E−01, ns p = 9.20E−01, **** p = 2.90E−05, ns p = 6.78E−01, ns p = 9.71E−01. Data information: Statistics were performed using unpaired Student’s t-test ( A , E , F , J ). Means and SDs are shown ( A , E , F , J ). ns, no significance. Scale bars, 10 µm ( B , G , H ). .
    Figure Legend Snippet: ( A – C ) HeLa cells were transfected with control siRNA, ATRX siRNA, and/or Wapl siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from 1000 cells per condition across three independent experiments. p values from left to right: *** p = 1.05E−04, * p = 4.10E−02 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX, Wapl, and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, ns p = 8.92E−02 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, ns p = 4.73E−02 ( F ). Representative images are shown ( G ). ( H, I ) HeLa cells transfected as described above were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative images are shown ( H ). Cell lysates were analyzed by immunoblotting for Wapl and α-Tubulin ( I ). ( J ) HeLa cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 700 cells per condition across three independent experiments. p values from left to right: * p = 2.73E−02, ns p = 3.80E−01, ns p = 9.86E−01, ** p = 2.36E−03, ns p = 7.80E−01, ns p = 4.34E−01, *** p = 1.85E−04, ns p = 7.17E−02, ns p = 3.57E−01, *** p = 1.21E−04, ns p = 6.58E−01, ns p = 9.20E−01, **** p = 2.90E−05, ns p = 6.78E−01, ns p = 9.71E−01. Data information: Statistics were performed using unpaired Student’s t-test ( A , E , F , J ). Means and SDs are shown ( A , E , F , J ). ns, no significance. Scale bars, 10 µm ( B , G , H ). .

    Techniques Used: Transfection, Control, Staining, Western Blot

    ( A ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST, followed by immunoblotting for the Myc tag and CBB staining. ( B ) Multiple sequence alignment of ATRX, Wapl, Sororin, Haspin, and PD-L1. ( C ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( D ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, GFP, and CBB staining. ( E ) MBP-Pds5B (1–300) was subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for MBP, GFP, and CBB staining. ( F ) HeLa cells stably expressing Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for Wapl, GFP, GAPDH, and the Myc tag. S. exp., short exposure; L. exp., long exposure. ( G ) Nocodazole-arrested mitotic HeLa cells were immunoprecipitated using the ATRX antibody or control IgG, followed by immunoblotting for ATRX, Pds5B, and Wapl. ( H ) Nocodazole-arrested mitotic HeLa cells stably expressing Wapl-GFP were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP, Pds5B, and ATRX. ( I ) HeLa cells stably expressing Myc-Pds5B, synchronized in G2-phase by double thymidine block/release or arrested in mitosis by nocodazole, were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for the Myc tag, Wapl, Sororin, ATRX, and GAPDH. .
    Figure Legend Snippet: ( A ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST, followed by immunoblotting for the Myc tag and CBB staining. ( B ) Multiple sequence alignment of ATRX, Wapl, Sororin, Haspin, and PD-L1. ( C ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( D ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, GFP, and CBB staining. ( E ) MBP-Pds5B (1–300) was subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for MBP, GFP, and CBB staining. ( F ) HeLa cells stably expressing Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for Wapl, GFP, GAPDH, and the Myc tag. S. exp., short exposure; L. exp., long exposure. ( G ) Nocodazole-arrested mitotic HeLa cells were immunoprecipitated using the ATRX antibody or control IgG, followed by immunoblotting for ATRX, Pds5B, and Wapl. ( H ) Nocodazole-arrested mitotic HeLa cells stably expressing Wapl-GFP were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP, Pds5B, and ATRX. ( I ) HeLa cells stably expressing Myc-Pds5B, synchronized in G2-phase by double thymidine block/release or arrested in mitosis by nocodazole, were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for the Myc tag, Wapl, Sororin, ATRX, and GAPDH. .

    Techniques Used: Expressing, Western Blot, Staining, Sequencing, Stable Transfection, Immunoprecipitation, Control, Blocking Assay

    ( A – C ) HeLa and Haspin KO cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2, 4, and 6 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was quantified from more than 720 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, ** p = 2.53E−03, ** p = 4.86E−03, * p = 1.38E−02, *** p = 2.19E−04, **** p = 4.70E−05, *** p = 6.23E−04, ** p = 2.88E−03, *** p = 1.93E−04, *** p = 1.19E−04, *** p = 2.55E−04, *** p = 4.02E−04 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 740 cells per condition across three independent experiments. p values from left to right: ** p = 2.41E−03, ** p = 2.20E−03, ** p = 4.81E−03, ** p = 2.70E−03, ** p = 3.79E−03, ** p = 2.21E−03, ** p = 4.51E−03, ** p = 3.71E−03, *** p = 3.87E−04, *** p = 1.42E−04, **** p = 2.50E−05, *** p = 1.08E−04. ( E ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was determined from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 3.70E−05, **** p = 5.10E−05, *** p = 8.31E−04, ** p = 2.42E−03. ( F ) Model for the role of ATRX in antagonizing Wapl and maintaining centromeric cohesion during mitosis. ATRX is enriched at the bipartite subdomains of the inner centromere, where it binds to Pds5B to antagonize Wapl binding, thereby preventing Wapl-mediated release of centromeric cohesin. Note that another pool of cohesin, in which Pds5B binds to Haspin, is also present at the inner centromere. Data information: Statistics were performed using unpaired Student’s t-test ( A , D , E ). Means and SDs are shown ( A , D , E ). Scale bars, 10 µm ( B ). .
    Figure Legend Snippet: ( A – C ) HeLa and Haspin KO cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2, 4, and 6 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was quantified from more than 720 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, ** p = 2.53E−03, ** p = 4.86E−03, * p = 1.38E−02, *** p = 2.19E−04, **** p = 4.70E−05, *** p = 6.23E−04, ** p = 2.88E−03, *** p = 1.93E−04, *** p = 1.19E−04, *** p = 2.55E−04, *** p = 4.02E−04 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 740 cells per condition across three independent experiments. p values from left to right: ** p = 2.41E−03, ** p = 2.20E−03, ** p = 4.81E−03, ** p = 2.70E−03, ** p = 3.79E−03, ** p = 2.21E−03, ** p = 4.51E−03, ** p = 3.71E−03, *** p = 3.87E−04, *** p = 1.42E−04, **** p = 2.50E−05, *** p = 1.08E−04. ( E ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was determined from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 3.70E−05, **** p = 5.10E−05, *** p = 8.31E−04, ** p = 2.42E−03. ( F ) Model for the role of ATRX in antagonizing Wapl and maintaining centromeric cohesion during mitosis. ATRX is enriched at the bipartite subdomains of the inner centromere, where it binds to Pds5B to antagonize Wapl binding, thereby preventing Wapl-mediated release of centromeric cohesin. Note that another pool of cohesin, in which Pds5B binds to Haspin, is also present at the inner centromere. Data information: Statistics were performed using unpaired Student’s t-test ( A , D , E ). Means and SDs are shown ( A , D , E ). Scale bars, 10 µm ( B ). .

    Techniques Used: Transfection, Control, Staining, Western Blot, Binding Assay

    Related Articles

    other:

    Article Title: Neuropilin-2 regulates ?6?1 integrin in the formation of focal adhesions and signaling
    Article Snippet: Antibodies against the following proteins were used: α3 integrin (Millipore, Billerica, MA) used for immunoblotting, or P1B5 (Gibco, Invitrogen, used for immunofluorescence); α6 integrin (AA6A, provided by Anne Cress, University of Arizona Cancer Center, Tucson, AZ, USA; J8H, provided by Arnoud Sonnenberg, The Netherlands Cancer Center, Amsterdam, The Netherlands; and GoH3, purchased from Millipore); β1 integrin (AIIB2, Developmental Studies Hybridoma Bank, Iowa); β4 integrin (439-9b, provided by Rita Falcioni (Regina Elena Cancer Institute, Rome, Italy); NRP2 (goat IgG, R&D, Minneapolis, MN; C9 and H300, Santa Cruz Biotechnology, Santa Cruz, CA); vinculin (Sigma); actin (Sigma); FAK- P (Y397) [mouse IgG (BD Bioscience) used for immunoblotting; rabbit IgG (AbCaM, Cambridge, MA, USA) used for immunofluorescence]; FLAG (Sigma); anti-rabbit-FITC; anti-goat FITC; anti-goat TRITC; rat IgG; mouse IgG (Jackson, West Grove, PA, USA); pan-phosphorylated-PKC S660; Src, phosphorylated-Src Y418; ERK, phosphorylated ERK (Cell Signaling, Beverly, MA, USA); PKCα (H7) and FAK (Santa Cruz Biotechnology); EpCAM (AbCaM) and VEGF (Calbiochem).

    Article Title: Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition
    Article Snippet: Immunostaining and immunofluorescence with following antibodies: F4/80 (Caltag Laboratories, Burlingame, CA), pro-SPC (Seven Hills Bioreagents, Cincinnati, OH), α-SMA, β-galactosidase (Abcam, Cambridge, MA), CD3, Vimentin C20 and Foxm1 K19 and H300 (all from Santa Cruz Biotechnology, Santa Cruz, CA), were done as previously described (Balli et al ; Wang et al, 2009 ).

    Article Title: Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis
    Article Snippet: Ishiguro et al. [ ] , NR , , Low grade (53), high grade (96) , , NR , , IHC , H300, NR, Santa Cruz Biotechnology, 1:200 , ≥1% , Nuclear , 129 (86.6).

    Article Title: Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.
    Article Snippet: Blots were blocked with 5% nonfat milk in PBS with 0.1% Tween 20 (PBST) and then developed with diluted antibodies for pSmad1 (1:1000 dilution; pS1 antibody [7]), Nur77 (1:1000 dilution; Abcam), and vinculin (1:1000 dilution; H300; Santa Cruz) at 4°C overnight, followed by horseradish peroxidaseconjugated anti-mouse or anti-rabbit (GE Healthcare) secondary antibodies using an ECL system (Fisher Scientific).

    Expressing:

    Article Title: Neural cell adhesion molecule stimulates survival of premyelinating oligodendrocytes via the fibroblast growth factor receptor.
    Article Snippet: Axonal signals are critical in promoting the survival and maturation of oligodendrocytes during myelination, with contact-dependent signals thought to play a key role.. However, the exact nature of these signals remains unclear.. Neural cell adhesion molecule (NCAM) is expressed by both axons and oligodendrocytes and is ideally localized to transduce signals from the axon.

    Membrane:

    Article Title: Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1.
    Article Snippet: The protein bands were visualized using an ECL Plus Western Blotting Detection System (Amersham Pharmacia Biotech). .. Then, the membrane was washed and re-blotted with the H300 antibody recognizing the C-terminus of Dnmt1 (rabbit, Santa Cruz). .. The relative amounts of proteins were estimated by densitometry using the ImageJ software (NIH).



    Similar Products

    90
    Santa Cruz Biotechnology atrx h300 antibody
    ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for <t>ATRX</t> and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.
    Atrx H300 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+gr/pmc12264150-447-7-9
    Average 90 stars, based on 1 article reviews
    atrx h300 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology pgc1α h300 antibody
    ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for <t>ATRX</t> and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.
    Pgc1α H300 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+pgc+1%CE%B1/pm40268923-278-5-7
    Average 90 stars, based on 1 article reviews
    pgc1α h300 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology pgc1α h300 santa cruz biotechnology #sc-13067 antibody
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Pgc1α H300 Santa Cruz Biotechnology #Sc 13067 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+pgc+1%CE%B1/pmc12019391-299-5-7
    Average 90 stars, based on 1 article reviews
    pgc1α h300 santa cruz biotechnology #sc-13067 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology fas h300 antibody
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Fas H300 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+gr/pm40090516-84-19-22
    Average 90 stars, based on 1 article reviews
    fas h300 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology myh h300
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Myh H300, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/MYH+Antibody/pm39210809-96-19-22
    Average 96 stars, based on 1 article reviews
    myh h300 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit anti pgc 1α h300
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Rabbit Anti Pgc 1α H300, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/PGC-1%CE%B1+Antibody/pm38648865-126-64-68
    Average 96 stars, based on 1 article reviews
    rabbit anti pgc 1α h300 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology antibody rabbit anti-pgc-1α (h300) sc13067
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Antibody Rabbit Anti Pgc 1α (H300) Sc13067, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+gr/pm38648865-126-71-68
    Average 90 stars, based on 1 article reviews
    antibody rabbit anti-pgc-1α (h300) sc13067 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit anti-car polyclonal antibody car h300
    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by <t>PGC1α</t> non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.
    Rabbit Anti Car Polyclonal Antibody Car H300, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/anti+gr/pmc10878518-73-16-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-car polyclonal antibody car h300 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology msh3 h300 rabbit polyclonal
    Fig. 2. MutSβ deficiency induces R-loop-dependent replication stress. (A to F) <t>MSH3</t> depletion induces replication fork stalling and micronucleation in U2OS cells. (A) Top: Workflow of DNA fiber assays. Bottom: Representative images of replication tracts on DNA fibers of cells transfected with indicated siRNAs. (B) Quantification of the lengths of replication tracts (CldU + IdU) in the images represented in (A) (n ≥ 311). (C) Representative images of symmetric and asymmetric replication tracts of sister forks observed on DNA fiber spreads in (A). (D) Plot of the values of IdU tract length ratio of sister forks (sister fork ratio) obtained for indicated conditions (n ≥ 120). (E) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Representative images of binucleated cells with or without micronucleus (red arrow). (F) Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). (G to K) RNase H1 overexpression rescues replication fork stalling and micronucleation in MSH3-depleted cells. (G) Western blot analysis of extracts of U2OS T-REx [RNH1-GFP] cells transfected with indicated siRNAs and treated with (+) or without (−) doxycycline (Dox; 1 ng/ml) to induce expression of GFP-tagged RNase H1 (RNH1-GFP). (H) Workflow of DNA fiber assays. (I) Quantification of the lengths of DNA replication tracts for indicated conditions (n ≥ 402). (J) Plot of the values of sister fork ratio obtained for indicated conditions (n ≥ 211). (K) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (B), (D), (I), and (J). ****P < 0.0001. One-way ANOVA with Tukey’s mul- tiple comparisons correction was used in (F) and (K). ***P < 0.001 and *P < 0.05. All DNA fiber experiments were performed three times. Red lines represent median val- ues. Scale bars, 10 μm. ns, not significant.
    Msh3 H300 Rabbit Polyclonal, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h300+antibody/MSH3+Antibody/pm38324687-299-14-20
    Average 93 stars, based on 1 article reviews
    msh3 h300 rabbit polyclonal - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for ATRX and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) Schematic diagram illustrating sister chromatid cohesion mediated by the ring-shaped cohesin complex. ( B ) Nocodazole-arrested mitotic HeLa cells stably expressing Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for ATRX and the Myc tag. ( C ) HEK-293T cells co-expressing ATRX-GFP with Myc-Pds5A or Myc-Pds5B were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP and the Myc tag. ( D ) HEK-293T cells expressing SFB-ATRX were immunoprecipitated using anti-Flag beads or control IgG, followed by immunoblotting for the Flag tag, Pds5B, SMC1A, and RAD21.

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Stable Transfection, Expressing, Immunoprecipitation, Control, Western Blot, FLAG-tag

    ( A , B ) HEK-293T cells expressing Myc-Pds5B were subjected to immunoprecipitation using anti-Myc beads or control IgG, followed by mass spectrometry ( A ) or immunoblotting with antibodies against the Myc tag, ATRX, and RAD21 ( B ). ( C , D ) HEK-293T cells expressing Myc-Pds5B and/or ATRX-GFP were immunoprecipitated using anti-Myc ( C ) or anti-GFP ( D ) beads, followed by immunoblotting for the Myc tag, GFP, GAPDH, or α-Tubulin as indicated. ( E ) HeLa cells stably expressing ATRX-GFP were transfected with control or Pds5B-targeting siRNA. Forty-eight hours post-transfection, cells were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, Pds5B, SMC1A, SMC3, and RAD21. ( F – I ) HEK-293T cells co-expressing ATRX-GFP and Myc-tagged SMC1A ( F ), SMC3 ( G ), RAD21 ( H ), or SA2 ( I ) were immunoprecipitated using anti-GFP beads and immunoblotted for GFP and the Myc tag. Myc-Pds5B co-transfection was used as a positive control. .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A , B ) HEK-293T cells expressing Myc-Pds5B were subjected to immunoprecipitation using anti-Myc beads or control IgG, followed by mass spectrometry ( A ) or immunoblotting with antibodies against the Myc tag, ATRX, and RAD21 ( B ). ( C , D ) HEK-293T cells expressing Myc-Pds5B and/or ATRX-GFP were immunoprecipitated using anti-Myc ( C ) or anti-GFP ( D ) beads, followed by immunoblotting for the Myc tag, GFP, GAPDH, or α-Tubulin as indicated. ( E ) HeLa cells stably expressing ATRX-GFP were transfected with control or Pds5B-targeting siRNA. Forty-eight hours post-transfection, cells were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, Pds5B, SMC1A, SMC3, and RAD21. ( F – I ) HEK-293T cells co-expressing ATRX-GFP and Myc-tagged SMC1A ( F ), SMC3 ( G ), RAD21 ( H ), or SA2 ( I ) were immunoprecipitated using anti-GFP beads and immunoblotted for GFP and the Myc tag. Myc-Pds5B co-transfection was used as a positive control. .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Expressing, Immunoprecipitation, Control, Mass Spectrometry, Western Blot, Stable Transfection, Transfection, Cotransfection, Positive Control

    ( A ) HEK-293T cells co-expressing ATRX-GFP and the indicated Pds5B-Flag truncations were immunoprecipitated using anti-GFP beads and analyzed by immunoblotted for GFP, the Flag tag, and α-Tubulin. ( B ) Schematic representation of GST-Pds5B (1–300) binding to ATRX mutants. ( C – G ) Pull-down assays of the indicated ATRX-GFP truncations using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and Coomassie Brilliant Blue (CBB) staining. ( H ) HEK-293T cells expressing ATRX-GFP (WT or Y1419A) and/or Myc-Pds5B were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, the Myc tag, and α-Tubulin. ( I ) Alignment of ATRX sequences from multiple species surrounding the conserved RSYK motif. ( J ) AlphaFold3 model of the ATRX (RSYKQ) peptide bound to Pds5B (1–300). ATRX (RSYKQ) is shown as sticks, and Pds5B as an electrostatic surface. The interaction between Y1419 of ATRX and Pds5B residues F88, A92, V138, and I143 is highlighted. .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HEK-293T cells co-expressing ATRX-GFP and the indicated Pds5B-Flag truncations were immunoprecipitated using anti-GFP beads and analyzed by immunoblotted for GFP, the Flag tag, and α-Tubulin. ( B ) Schematic representation of GST-Pds5B (1–300) binding to ATRX mutants. ( C – G ) Pull-down assays of the indicated ATRX-GFP truncations using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and Coomassie Brilliant Blue (CBB) staining. ( H ) HEK-293T cells expressing ATRX-GFP (WT or Y1419A) and/or Myc-Pds5B were immunoprecipitated using anti-GFP beads and analyzed by immunoblotting for GFP, the Myc tag, and α-Tubulin. ( I ) Alignment of ATRX sequences from multiple species surrounding the conserved RSYK motif. ( J ) AlphaFold3 model of the ATRX (RSYKQ) peptide bound to Pds5B (1–300). ATRX (RSYKQ) is shown as sticks, and Pds5B as an electrostatic surface. The interaction between Y1419 of ATRX and Pds5B residues F88, A92, V138, and I143 is highlighted. .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Expressing, Immunoprecipitation, FLAG-tag, Binding Assay, Western Blot, Staining

    ( A ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( B – E ) Recombinant GFP-ATRX (1394–1443)-2xStrep (wild-type or mutants) proteins were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( F ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down using GFP-2xStrep or GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, and CBB staining. ( G ) Cartoon presentation of the structure for ATRX (RSYKQ) binding to Pds5B (1–300). ATRX and Pds5B residues are shown in yellow and gray, respectively. The binding details of ATRX residues R1417, S1418, Y1419, K1420, and Q1421 with Pds5B residues Q47, F88, A92, V138, and I143 are depicted. ( H , I ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( J ) HEK-293T cells expressing ATRX-GFP (WT, R1417A or R1417E) were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining.

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( B – E ) Recombinant GFP-ATRX (1394–1443)-2xStrep (wild-type or mutants) proteins were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining. ( F ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down using GFP-2xStrep or GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, and CBB staining. ( G ) Cartoon presentation of the structure for ATRX (RSYKQ) binding to Pds5B (1–300). ATRX and Pds5B residues are shown in yellow and gray, respectively. The binding details of ATRX residues R1417, S1418, Y1419, K1420, and Q1421 with Pds5B residues Q47, F88, A92, V138, and I143 are depicted. ( H , I ) HEK-293T cells expressing ATRX-GFP were subjected to pull-down using GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( J ) HEK-293T cells expressing ATRX-GFP (WT, R1417A or R1417E) were subjected to pull-down using GST or GST-Pds5B (1–300), followed by immunoblotting for GFP and CBB staining.

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Expressing, Western Blot, Staining, Recombinant, Binding Assay

    ( A – C ) HeLa cells were transfected with control or ATRX siRNA duplexes. Forty-eight hours post-transfection, cells were either analyzed by immunoblotting for ATRX and GAPDH ( A ) or treated with MG132 and then fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: ns p = 1.04E−01, ns p = 0.2203, * p = 4.93E−02, * p = 4.10E−02, ** p = 2.40E−03, * p = 0.018, ** p = 5.50E−03, ** p = 4.60E−03, ** p = 3.60E−03, **** p = 3.50E−05, **** p = 5.00E−06, **** p = 3.50E−05, **** p = 3.00E−06, **** p = 6.70E−05, **** p = 2.00E−06 ( B ). Representative images are shown, with arrows indicating misaligned chromosomes ( C ). ( D ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA and synchronized in early S phase with thymidine. Seven hours after thymidine release, cells were treated with STLC for 5 h. Mitotic cells were then collected and released into MG132-containing medium for live imaging of mitosis progression. The time from STLC washout to metaphase alignment and from metaphase to chromosome scattering or the imaging endpoint was recorded. See Movies and . ( E , F ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h. Mitotic cells were collected for chromosome spread preparation, stained with CENP-C antibodies and DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was determined from more than 930 cells per condition across three independent experiments. p values from left to right: ** p = 3.04E−03, *** p = 4.16E−04, ** p = 4.53E−03 ( E ). Representative images are shown ( F ). ( G , H ) HeLa cells were transfected as above, then fixed and stained with DAPI. The percentage of cells displaying lagging chromosomes was quantified from more than 490 cells per condition across three independent experiments. p values from left to right: *** p = 8.13E−04, ** p = 5.62E−03, * p = 2.54E−02 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). ( I ) HeLa cells were transfected as described above and treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 700 cells per condition across three independent experiments. p values from left to right: ** p = 2.86E−03, ** p = 4.19E−03, *** p = 4.63E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , E , G , I ). Means and standard deviations (SDs) are shown ( B , E , G , I ). ns, no significance. Scale bars, 10 µm ( C , F , H ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A – C ) HeLa cells were transfected with control or ATRX siRNA duplexes. Forty-eight hours post-transfection, cells were either analyzed by immunoblotting for ATRX and GAPDH ( A ) or treated with MG132 and then fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: ns p = 1.04E−01, ns p = 0.2203, * p = 4.93E−02, * p = 4.10E−02, ** p = 2.40E−03, * p = 0.018, ** p = 5.50E−03, ** p = 4.60E−03, ** p = 3.60E−03, **** p = 3.50E−05, **** p = 5.00E−06, **** p = 3.50E−05, **** p = 3.00E−06, **** p = 6.70E−05, **** p = 2.00E−06 ( B ). Representative images are shown, with arrows indicating misaligned chromosomes ( C ). ( D ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA and synchronized in early S phase with thymidine. Seven hours after thymidine release, cells were treated with STLC for 5 h. Mitotic cells were then collected and released into MG132-containing medium for live imaging of mitosis progression. The time from STLC washout to metaphase alignment and from metaphase to chromosome scattering or the imaging endpoint was recorded. See Movies and . ( E , F ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h. Mitotic cells were collected for chromosome spread preparation, stained with CENP-C antibodies and DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was determined from more than 930 cells per condition across three independent experiments. p values from left to right: ** p = 3.04E−03, *** p = 4.16E−04, ** p = 4.53E−03 ( E ). Representative images are shown ( F ). ( G , H ) HeLa cells were transfected as above, then fixed and stained with DAPI. The percentage of cells displaying lagging chromosomes was quantified from more than 490 cells per condition across three independent experiments. p values from left to right: *** p = 8.13E−04, ** p = 5.62E−03, * p = 2.54E−02 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). ( I ) HeLa cells were transfected as described above and treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 700 cells per condition across three independent experiments. p values from left to right: ** p = 2.86E−03, ** p = 4.19E−03, *** p = 4.63E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , E , G , I ). Means and standard deviations (SDs) are shown ( B , E , G , I ). ns, no significance. Scale bars, 10 µm ( C , F , H ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Transfection, Control, Western Blot, Staining, Stable Transfection, Expressing, Imaging

    ( A ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA, followed by live imaging of mitosis progression. Selected movie frames are shown. Time is indicated in hours: minutes. Arrows point to scattering chromosomes. Related to Fig. . ( B , C ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. Representative super-resolution images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( F ). Representative images are shown ( G ). ( H – L ) HeLa cells were transfected with the indicated siRNAs, co-transfected with NLS-dCas9-EGFP-expressing vector and the sgRNA-expressing vector, and synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for GFP and DAPI. Representative images are shown ( H ). The sister loci distance was measured in more than 450 cells per condition across two independent experiments, and the means and ranges are plotted ( I ). Sister loci distances from two individual experiments are shown. p values from left to right: ns p = 6.12E−01, **** p < 1.00E−15 ( J ). ns p = 3.95E−01, **** p < 1.00E−15 ( K ). Cell lysates were analyzed by immunoblotting for ATRX, Sororin, and GAPDH ( L ). Data information: Statistics were performed using unpaired Student’s t-test ( E , F , J , K ). Means and SDs are shown ( E , F , J , K ). ns, no significance. Scale bars, 10 µm ( A , B , G , H ).

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HeLa cells stably expressing H2B-GFP were transfected with control or ATRX siRNA, followed by live imaging of mitosis progression. Selected movie frames are shown. Time is indicated in hours: minutes. Arrows point to scattering chromosomes. Related to Fig. . ( B , C ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. Representative super-resolution images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, **** p < 1.00E−15 ( F ). Representative images are shown ( G ). ( H – L ) HeLa cells were transfected with the indicated siRNAs, co-transfected with NLS-dCas9-EGFP-expressing vector and the sgRNA-expressing vector, and synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for GFP and DAPI. Representative images are shown ( H ). The sister loci distance was measured in more than 450 cells per condition across two independent experiments, and the means and ranges are plotted ( I ). Sister loci distances from two individual experiments are shown. p values from left to right: ns p = 6.12E−01, **** p < 1.00E−15 ( J ). ns p = 3.95E−01, **** p < 1.00E−15 ( K ). Cell lysates were analyzed by immunoblotting for ATRX, Sororin, and GAPDH ( L ). Data information: Statistics were performed using unpaired Student’s t-test ( E , F , J , K ). Means and SDs are shown ( E , F , J , K ). ns, no significance. Scale bars, 10 µm ( A , B , G , H ).

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Stable Transfection, Expressing, Transfection, Control, Imaging, Staining, Western Blot, Plasmid Preparation

    ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h. Mitotic cells were collected for chromosome spread preparation and subjected to immunofluorescence staining with ATRX and CENP-C antibodies, and DAPI. ( B ) HeLa and HP1α/γ DKO cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. ( C , D ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative super-resolution images are shown ( C ). The number of centromeric ATRX foci was quantified from more than 299 chromosomes per condition across two independent experiments ( D ). ( E ) HeLa cells stably expressing siRNA-resistant ATRX-GFP (WT or Y1419A) were analyzed by immunoblotting for ATRX, GFP, and GAPDH. ( F ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were arrested in mitosis with nocodazole, immunoprecipitated using anti-GFP beads, and analyzed by immunoblotting for Pds5B, HP1α, and GFP. S. exp., short exposure; L. exp., long exposure. ( G , H ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. Representative super-resolution images are shown ( G ). The number of centromeric ATRX foci was quantified from more than 46 chromosomes ( H ). Data information: Scale bars, 10 µm ( A , B , C , G ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 2 h. Mitotic cells were collected for chromosome spread preparation and subjected to immunofluorescence staining with ATRX and CENP-C antibodies, and DAPI. ( B ) HeLa and HP1α/γ DKO cells were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. ( C , D ) HeLa cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative super-resolution images are shown ( C ). The number of centromeric ATRX foci was quantified from more than 299 chromosomes per condition across two independent experiments ( D ). ( E ) HeLa cells stably expressing siRNA-resistant ATRX-GFP (WT or Y1419A) were analyzed by immunoblotting for ATRX, GFP, and GAPDH. ( F ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were arrested in mitosis with nocodazole, immunoprecipitated using anti-GFP beads, and analyzed by immunoblotting for Pds5B, HP1α, and GFP. S. exp., short exposure; L. exp., long exposure. ( G , H ) HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were treated with MG132 for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. Representative super-resolution images are shown ( G ). The number of centromeric ATRX foci was quantified from more than 46 chromosomes ( H ). Data information: Scale bars, 10 µm ( A , B , C , G ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Transfection, Control, Immunofluorescence, Staining, Stable Transfection, Expressing, Western Blot, Immunoprecipitation

    ( A ) HeLa cells stably expressing Myc-Pds5B were synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for ATRX, the Myc tag, ACA, and DAPI. Representative images are shown. ( B ) HeLa cells were synchronized in G2 phase as described above and stained for ATRX, HP1α, ACA, and DAPI. Representative images are shown. ( C ) HeLa and HP1α/γ DKO cells were stained for ATRX, HP1α, CENP-C, and DAPI. Representative images are shown. ( D , E ) HeLa cells were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. The fluorescence intensity ratio of ATRX to ACA was quantified on more than 230 chromosomes from 15–20 cells. p values from left to right: ns p = 6.59E−02, ns p = 1.91E−01, ns p = 9.35E−01, ns p = 2.07E−01 ( D ). Representative images are shown ( E ). ( F – H ) HeLa cells stably expressing Sororin-GFP were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The fluorescence intensity ratio of Sororin-GFP to ACA was quantified on more than 195 chromosomes from 15 to 20 cells. p values from left to right: **** p < 1E−15, **** p < 1E−15, **** p < 1E−15, **** p < 1E−15 ( F ). Representative images are shown ( G ). Cell lysates were analyzed by immunoblotting for GFP and α-Tubulin ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( D , F ). Means and SDs are shown ( D , F ). N.S., no significance. Scale bars, 10 µm ( A , B , C , E , G ).

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HeLa cells stably expressing Myc-Pds5B were synchronized using double thymidine treatment. Eight hours after release from thymidine, cells were stained for ATRX, the Myc tag, ACA, and DAPI. Representative images are shown. ( B ) HeLa cells were synchronized in G2 phase as described above and stained for ATRX, HP1α, ACA, and DAPI. Representative images are shown. ( C ) HeLa and HP1α/γ DKO cells were stained for ATRX, HP1α, CENP-C, and DAPI. Representative images are shown. ( D , E ) HeLa cells were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. The fluorescence intensity ratio of ATRX to ACA was quantified on more than 230 chromosomes from 15–20 cells. p values from left to right: ns p = 6.59E−02, ns p = 1.91E−01, ns p = 9.35E−01, ns p = 2.07E−01 ( D ). Representative images are shown ( E ). ( F – H ) HeLa cells stably expressing Sororin-GFP were treated with nocodazole for 3 h or with MG132 for 1, 3, and 6 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The fluorescence intensity ratio of Sororin-GFP to ACA was quantified on more than 195 chromosomes from 15 to 20 cells. p values from left to right: **** p < 1E−15, **** p < 1E−15, **** p < 1E−15, **** p < 1E−15 ( F ). Representative images are shown ( G ). Cell lysates were analyzed by immunoblotting for GFP and α-Tubulin ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( D , F ). Means and SDs are shown ( D , F ). N.S., no significance. Scale bars, 10 µm ( A , B , C , E , G ).

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Stable Transfection, Expressing, Staining, Fluorescence, Western Blot

    ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were analyzed by immunoblotting for ATRX, RAD21, SMC1A, SMC3, SA2, Pds5B, Sororin, Wapl, and GAPDH. ( B , C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected as described above, treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments. p values from left to right: **** p < 1.00E−15. ns p = 1.01E−01, **** p < 1.00E−15 ( B ). **** p < 1.00E−15 ( J ). ns p = 5.10E−01, **** p < 1.00E−15 ( C ). Related to Fig. . ( D , E ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were subjected to mitotic index analysis. The mitotic index was determined from more than 940 cells per condition across two independent experiments ( D ). Representative images of cells are shown, with round cells classified as mitotic ( E ). ( F ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) transfected as described above were treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: **** p = 5.30E−05. **** p = 5.00E−05, ns p = 9.92E−01, ns p = 2.09E−01. **** p = 2.44E−04. **** p = 2.29E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , C , F ). Means and SDs are shown ( B , C , F ). ns, no significance. Scale bars, 10 µm ( E ).

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HeLa cells were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were analyzed by immunoblotting for ATRX, RAD21, SMC1A, SMC3, SA2, Pds5B, Sororin, Wapl, and GAPDH. ( B , C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected as described above, treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments. p values from left to right: **** p < 1.00E−15. ns p = 1.01E−01, **** p < 1.00E−15 ( B ). **** p < 1.00E−15 ( J ). ns p = 5.10E−01, **** p < 1.00E−15 ( C ). Related to Fig. . ( D , E ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were subjected to mitotic index analysis. The mitotic index was determined from more than 940 cells per condition across two independent experiments ( D ). Representative images of cells are shown, with round cells classified as mitotic ( E ). ( F ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) transfected as described above were treated with STLC for 5 h. Two hours after STLC release, cells were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was quantified from more than 560 cells per condition across three independent experiments. p values from left to right: **** p = 5.30E−05. **** p = 5.00E−05, ns p = 9.92E−01, ns p = 2.09E−01. **** p = 2.44E−04. **** p = 2.29E−04. Data information: Statistics were performed using unpaired Student’s t-test ( B , C , F ). Means and SDs are shown ( B , C , F ). ns, no significance. Scale bars, 10 µm ( E ).

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Transfection, Control, Western Blot, Stable Transfection, Expressing, Staining

    ( A – C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 500 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, *** p = 7.60E−04, ns p = 3.31E−01, ns p = 7.75E−02, *** p = 3.77E−04, **** p = 9.60E−05 ( A ). Representative images are shown ( B ). Cell lysates were immunoblotted for ATRX, GFP, and GAPDH ( C ). ( D , E ) Cells transfected with siRNAs as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments (see Fig. ). Means and ranges are plotted ( D ). Representative images are shown ( E ). ( F ) Cells transfected with siRNAs as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 620 cells per condition across three independent experiments. p values from left to right: ns p = 1.40E−01. ns p = 6.74E−02, ** p = 1.71E−03, ** p = 1.48E−03. ns p = 6.43E−02. ** p = 6.81E−03, *** p = 4.86E−04, **** p = 4.70E−05 (HeLa). ns p = 5.39E−02. * p = 1.32E−02, *** p = 6.11E−04, *** p = 5.09E−04. * p = 2.47E−02. * p = 2.26E−02, ** p = 1.60E−03, ** p = 1.30E−03 (ATRX-GFP). ns p = 1.47E−01. * p = 1.99E−02, ** p = 1.64E−03, ** p = 1.25E−03. * p = 4.43E−02. ** p = 2.78E−03, *** p = 1.38E−04, **** p = 4.25E−07 (ATRX-Y1419A-GFP). ( G , H ) Cells transfected with siRNAs as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was determined from more than 530 cells per condition across three independent experiments. p values from left to right: ** p = 1.69E−03, *** p = 1.86E−04, ns p = 5.64E−01, ns p = 2.70E−01, ** p = 1.06E−03, ** p = 1.16E−03 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( A , F , G ). Means and SDs are shown ( A , F , G ). ns, no significance. Scale bars, 10 µm ( B , E , H ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A – C ) HeLa and HeLa cells stably expressing ATRX-GFP (WT or Y1419A) were transfected with control or ATRX siRNAs. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 500 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, *** p = 7.60E−04, ns p = 3.31E−01, ns p = 7.75E−02, *** p = 3.77E−04, **** p = 9.60E−05 ( A ). Representative images are shown ( B ). Cell lysates were immunoblotted for ATRX, GFP, and GAPDH ( C ). ( D , E ) Cells transfected with siRNAs as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for GFP, ACA, and DAPI. The inter-KT distance was measured on more than 1750 chromosomes from 80 cells per condition across two independent experiments (see Fig. ). Means and ranges are plotted ( D ). Representative images are shown ( E ). ( F ) Cells transfected with siRNAs as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 620 cells per condition across three independent experiments. p values from left to right: ns p = 1.40E−01. ns p = 6.74E−02, ** p = 1.71E−03, ** p = 1.48E−03. ns p = 6.43E−02. ** p = 6.81E−03, *** p = 4.86E−04, **** p = 4.70E−05 (HeLa). ns p = 5.39E−02. * p = 1.32E−02, *** p = 6.11E−04, *** p = 5.09E−04. * p = 2.47E−02. * p = 2.26E−02, ** p = 1.60E−03, ** p = 1.30E−03 (ATRX-GFP). ns p = 1.47E−01. * p = 1.99E−02, ** p = 1.64E−03, ** p = 1.25E−03. * p = 4.43E−02. ** p = 2.78E−03, *** p = 1.38E−04, **** p = 4.25E−07 (ATRX-Y1419A-GFP). ( G , H ) Cells transfected with siRNAs as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was determined from more than 530 cells per condition across three independent experiments. p values from left to right: ** p = 1.69E−03, *** p = 1.86E−04, ns p = 5.64E−01, ns p = 2.70E−01, ** p = 1.06E−03, ** p = 1.16E−03 ( G ). Representative images are shown, with arrows indicating lagging chromosomes ( H ). Data information: Statistics were performed using unpaired Student’s t-test ( A , F , G ). Means and SDs are shown ( A , F , G ). ns, no significance. Scale bars, 10 µm ( B , E , H ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Stable Transfection, Expressing, Transfection, Control, Staining

    ( A ) HeLa cells stably expressing CB-GFP or CB-ATRX (1394–1443)-GFP (WT or Y1419A) were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin. ( B – D ) HeLa cells stably expressing the indicated proteins were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 770 cells per condition across three independent experiments. p values from left to right: *** p = 6.69E−04, ns p = 5.30E−01, ** p = 1.04E−03 ( B ). Representative images are shown ( C ). Cell lysates were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin ( D ). ( E – H ) Cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-A and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 90 cells per condition across two independent experiments, and the means and ranges are plotted ( E ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, * p = 3.62E−02, **** p = 7.27E−06 ( F ). **** p < 1.00E−15, ns p = 1.11E−01, **** p < 1.00E−15 ( G ). Representative images are shown ( H ). ( I ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes were determined from more than 670 cells per condition across three independent experiments. p values from left to right: ns p = 6.74E−02. ns p = 6.02E−02, ** p = 3.47E−03, ** p = 2.39E−03. * p = 2.21E−02. ** p = 6.22E−03, *** p = 3.34E−04, **** p = 6.14E−07 (CB-GFP). ** p = 1.20E−03. * p = 1.1E−02, ** p = 1.21E−03, ** p = 1.55E−03. * p = 4.76E−02. * p = 1.50E−02, *** p = 1.25E−04, *** p = 1.10E−04 (CB-ATRX (1394–1443)-GFP). ns p = 1.23E−01. * p = 3.33E−02, ** p = 1.15E−03, *** p = 6.70E−04. * p = 1.36E−02. ** p = 2.20E−03, **** p = 3.70E−05, **** p = 6.32E−06 (CB-ATRX (1394–1443)-GFP-Y1419A). ( J ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was quantified from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 4.40E−05, * p = 1.10E−02, **** p = 3.90E−05. Data information: Statistics were performed using unpaired Student’s t-test ( B , F , G , I , J ). Means and SDs are shown ( B , F , G , I , J ). ns, no significance. Scale bars, 10 µm ( C , H ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HeLa cells stably expressing CB-GFP or CB-ATRX (1394–1443)-GFP (WT or Y1419A) were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin. ( B – D ) HeLa cells stably expressing the indicated proteins were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from more than 770 cells per condition across three independent experiments. p values from left to right: *** p = 6.69E−04, ns p = 5.30E−01, ** p = 1.04E−03 ( B ). Representative images are shown ( C ). Cell lysates were analyzed by immunoblotting for GFP, ATRX, and α-Tubulin ( D ). ( E – H ) Cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-A and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 90 cells per condition across two independent experiments, and the means and ranges are plotted ( E ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, * p = 3.62E−02, **** p = 7.27E−06 ( F ). **** p < 1.00E−15, ns p = 1.11E−01, **** p < 1.00E−15 ( G ). Representative images are shown ( H ). ( I ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes were determined from more than 670 cells per condition across three independent experiments. p values from left to right: ns p = 6.74E−02. ns p = 6.02E−02, ** p = 3.47E−03, ** p = 2.39E−03. * p = 2.21E−02. ** p = 6.22E−03, *** p = 3.34E−04, **** p = 6.14E−07 (CB-GFP). ** p = 1.20E−03. * p = 1.1E−02, ** p = 1.21E−03, ** p = 1.55E−03. * p = 4.76E−02. * p = 1.50E−02, *** p = 1.25E−04, *** p = 1.10E−04 (CB-ATRX (1394–1443)-GFP). ns p = 1.23E−01. * p = 3.33E−02, ** p = 1.15E−03, *** p = 6.70E−04. * p = 1.36E−02. ** p = 2.20E−03, **** p = 3.70E−05, **** p = 6.32E−06 (CB-ATRX (1394–1443)-GFP-Y1419A). ( J ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells exhibiting lagging chromosomes was quantified from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 4.40E−05, * p = 1.10E−02, **** p = 3.90E−05. Data information: Statistics were performed using unpaired Student’s t-test ( B , F , G , I , J ). Means and SDs are shown ( B , F , G , I , J ). ns, no significance. Scale bars, 10 µm ( C , H ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Stable Transfection, Expressing, Western Blot, Transfection, Control, Staining

    ( A – C ) HeLa cells were transfected with control siRNA, ATRX siRNA, and/or Wapl siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from 1000 cells per condition across three independent experiments. p values from left to right: *** p = 1.05E−04, * p = 4.10E−02 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX, Wapl, and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, ns p = 8.92E−02 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, ns p = 4.73E−02 ( F ). Representative images are shown ( G ). ( H, I ) HeLa cells transfected as described above were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative images are shown ( H ). Cell lysates were analyzed by immunoblotting for Wapl and α-Tubulin ( I ). ( J ) HeLa cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 700 cells per condition across three independent experiments. p values from left to right: * p = 2.73E−02, ns p = 3.80E−01, ns p = 9.86E−01, ** p = 2.36E−03, ns p = 7.80E−01, ns p = 4.34E−01, *** p = 1.85E−04, ns p = 7.17E−02, ns p = 3.57E−01, *** p = 1.21E−04, ns p = 6.58E−01, ns p = 9.20E−01, **** p = 2.90E−05, ns p = 6.78E−01, ns p = 9.71E−01. Data information: Statistics were performed using unpaired Student’s t-test ( A , E , F , J ). Means and SDs are shown ( A , E , F , J ). ns, no significance. Scale bars, 10 µm ( B , G , H ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A – C ) HeLa cells were transfected with control siRNA, ATRX siRNA, and/or Wapl siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 8 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The percentage of mitotic cells exhibiting predominantly separated or unseparated sister chromatids was quantified from 1000 cells per condition across three independent experiments. p values from left to right: *** p = 1.05E−04, * p = 4.10E−02 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX, Wapl, and GAPDH ( C ). ( D – G ) HeLa cells transfected as described above were treated with nocodazole for 3 h, and mitotic chromosome spreads were stained for CENP-C and DAPI. The inter-KT distance was measured on more than 2000 chromosomes from 95 cells per condition across two independent experiments, and the means and ranges are plotted ( D ). Inter-KT distances from two individual experiments are shown. p values from left to right: **** p < 1.00E−15, **** p < 1.00E−15, ns p = 8.92E−02 ( E ). **** p < 1.00E−15, **** p < 1.00E−15, ns p = 4.73E−02 ( F ). Representative images are shown ( G ). ( H, I ) HeLa cells transfected as described above were treated with MG132 for 2 h, and mitotic chromosome spreads were stained for ATRX, ACA, and DAPI. Representative images are shown ( H ). Cell lysates were analyzed by immunoblotting for Wapl and α-Tubulin ( I ). ( J ) HeLa cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentages of mitotic cells in prometaphase, metaphase, and pseudo-metaphase exhibiting misaligned chromosomes were determined from more than 700 cells per condition across three independent experiments. p values from left to right: * p = 2.73E−02, ns p = 3.80E−01, ns p = 9.86E−01, ** p = 2.36E−03, ns p = 7.80E−01, ns p = 4.34E−01, *** p = 1.85E−04, ns p = 7.17E−02, ns p = 3.57E−01, *** p = 1.21E−04, ns p = 6.58E−01, ns p = 9.20E−01, **** p = 2.90E−05, ns p = 6.78E−01, ns p = 9.71E−01. Data information: Statistics were performed using unpaired Student’s t-test ( A , E , F , J ). Means and SDs are shown ( A , E , F , J ). ns, no significance. Scale bars, 10 µm ( B , G , H ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Transfection, Control, Staining, Western Blot

    ( A ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST, followed by immunoblotting for the Myc tag and CBB staining. ( B ) Multiple sequence alignment of ATRX, Wapl, Sororin, Haspin, and PD-L1. ( C ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( D ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, GFP, and CBB staining. ( E ) MBP-Pds5B (1–300) was subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for MBP, GFP, and CBB staining. ( F ) HeLa cells stably expressing Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for Wapl, GFP, GAPDH, and the Myc tag. S. exp., short exposure; L. exp., long exposure. ( G ) Nocodazole-arrested mitotic HeLa cells were immunoprecipitated using the ATRX antibody or control IgG, followed by immunoblotting for ATRX, Pds5B, and Wapl. ( H ) Nocodazole-arrested mitotic HeLa cells stably expressing Wapl-GFP were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP, Pds5B, and ATRX. ( I ) HeLa cells stably expressing Myc-Pds5B, synchronized in G2-phase by double thymidine block/release or arrested in mitosis by nocodazole, were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for the Myc tag, Wapl, Sororin, ATRX, and GAPDH. .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST, followed by immunoblotting for the Myc tag and CBB staining. ( B ) Multiple sequence alignment of ATRX, Wapl, Sororin, Haspin, and PD-L1. ( C ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or GST-Pds5B (1–300) (WT or mutants), followed by immunoblotting for GFP and CBB staining. ( D ) HEK-293T cells expressing Myc-Pds5B were subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for the Myc tag, GFP, and CBB staining. ( E ) MBP-Pds5B (1–300) was subjected to pull-down with GST or Wapl (1–28)-GST in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for MBP, GFP, and CBB staining. ( F ) HeLa cells stably expressing Myc-Pds5B were immunoprecipitated using anti-Myc beads or control IgG in the presence of GFP-2xStrep or increasing amounts of GFP-ATRX (1394–1443)-2xStrep (WT or Y1419A), followed by immunoblotting for Wapl, GFP, GAPDH, and the Myc tag. S. exp., short exposure; L. exp., long exposure. ( G ) Nocodazole-arrested mitotic HeLa cells were immunoprecipitated using the ATRX antibody or control IgG, followed by immunoblotting for ATRX, Pds5B, and Wapl. ( H ) Nocodazole-arrested mitotic HeLa cells stably expressing Wapl-GFP were immunoprecipitated using anti-GFP beads or control IgG, followed by immunoblotting for GFP, Pds5B, and ATRX. ( I ) HeLa cells stably expressing Myc-Pds5B, synchronized in G2-phase by double thymidine block/release or arrested in mitosis by nocodazole, were immunoprecipitated using anti-Myc beads or control IgG, followed by immunoblotting for the Myc tag, Wapl, Sororin, ATRX, and GAPDH. .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Expressing, Western Blot, Staining, Sequencing, Stable Transfection, Immunoprecipitation, Control, Blocking Assay

    ( A – C ) HeLa and Haspin KO cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2, 4, and 6 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was quantified from more than 720 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, ** p = 2.53E−03, ** p = 4.86E−03, * p = 1.38E−02, *** p = 2.19E−04, **** p = 4.70E−05, *** p = 6.23E−04, ** p = 2.88E−03, *** p = 1.93E−04, *** p = 1.19E−04, *** p = 2.55E−04, *** p = 4.02E−04 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 740 cells per condition across three independent experiments. p values from left to right: ** p = 2.41E−03, ** p = 2.20E−03, ** p = 4.81E−03, ** p = 2.70E−03, ** p = 3.79E−03, ** p = 2.21E−03, ** p = 4.51E−03, ** p = 3.71E−03, *** p = 3.87E−04, *** p = 1.42E−04, **** p = 2.50E−05, *** p = 1.08E−04. ( E ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was determined from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 3.70E−05, **** p = 5.10E−05, *** p = 8.31E−04, ** p = 2.42E−03. ( F ) Model for the role of ATRX in antagonizing Wapl and maintaining centromeric cohesion during mitosis. ATRX is enriched at the bipartite subdomains of the inner centromere, where it binds to Pds5B to antagonize Wapl binding, thereby preventing Wapl-mediated release of centromeric cohesin. Note that another pool of cohesin, in which Pds5B binds to Haspin, is also present at the inner centromere. Data information: Statistics were performed using unpaired Student’s t-test ( A , D , E ). Means and SDs are shown ( A , D , E ). Scale bars, 10 µm ( B ). .

    Journal: The EMBO Journal

    Article Title: A chromatin-remodeling-independent role for ATRX in protecting centromeric cohesion

    doi: 10.1038/s44318-025-00465-6

    Figure Lengend Snippet: ( A – C ) HeLa and Haspin KO cells were transfected with control or ATRX siRNA. Forty-eight hours post-transfection, cells were treated with MG132 for 2, 4, and 6 h, and mitotic chromosome spreads were stained with DAPI. The percentage of mitotic cells with predominantly separated or unseparated sister chromatids was quantified from more than 720 cells per condition across three independent experiments. p values from left to right: *** p = 8.95E−04, ** p = 2.53E−03, ** p = 4.86E−03, * p = 1.38E−02, *** p = 2.19E−04, **** p = 4.70E−05, *** p = 6.23E−04, ** p = 2.88E−03, *** p = 1.93E−04, *** p = 1.19E−04, *** p = 2.55E−04, *** p = 4.02E−04 ( A ). Representative images are shown ( B ). Cell lysates were analyzed by immunoblotting for ATRX and GAPDH ( C ). ( D ) Cells transfected as described above were treated with MG132 and fixed at the indicated time points for DAPI staining. The percentage of mitotic cells in prometaphase, metaphase, and pseudo-metaphase with misaligned chromosomes was quantified from more than 740 cells per condition across three independent experiments. p values from left to right: ** p = 2.41E−03, ** p = 2.20E−03, ** p = 4.81E−03, ** p = 2.70E−03, ** p = 3.79E−03, ** p = 2.21E−03, ** p = 4.51E−03, ** p = 3.71E−03, *** p = 3.87E−04, *** p = 1.42E−04, **** p = 2.50E−05, *** p = 1.08E−04. ( E ) Cells transfected as described above were fixed and stained with DAPI. The percentage of anaphase cells with lagging chromosomes was determined from more than 650 cells per condition across three independent experiments. p values from left to right: **** p = 3.70E−05, **** p = 5.10E−05, *** p = 8.31E−04, ** p = 2.42E−03. ( F ) Model for the role of ATRX in antagonizing Wapl and maintaining centromeric cohesion during mitosis. ATRX is enriched at the bipartite subdomains of the inner centromere, where it binds to Pds5B to antagonize Wapl binding, thereby preventing Wapl-mediated release of centromeric cohesin. Note that another pool of cohesin, in which Pds5B binds to Haspin, is also present at the inner centromere. Data information: Statistics were performed using unpaired Student’s t-test ( A , D , E ). Means and SDs are shown ( A , D , E ). Scale bars, 10 µm ( B ). .

    Article Snippet: The following rabbit polyclonal antibodies were used: ATRX (H300, Santa Cruz Biotechnology), GFP (A11122, Invitrogen), GAPDH (14C10, Cell Signaling Technology/CST), RAD21 (ab992, Abcam), SMC1A (A300-055A, Bethyl Laboratories), SMC3 (A300-060A, Bethyl Laboratories), Pds5B (A300-537A and A300-538A, Bethyl Laboratories), Sororin (ab192237, Abcam), and Flag tag (A01868, GenScript).

    Techniques: Transfection, Control, Staining, Western Blot, Binding Assay

    A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by PGC1α non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.

    Journal: Cell Death & Disease

    Article Title: Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer

    doi: 10.1038/s41419-025-07639-4

    Figure Lengend Snippet: A Schematic representation of the experimental approach for condition media production. B Quantification of 2D-cell proliferation in AR negative, PC3 ( n = 7) and DU145 ( n = 5) cells, and AR positive 22Rv1 ( n = 4) and LnCaP ( n = 4) cells grown with differential conditioned media produced by PGC1α non-expressing (CM (-D)) and expressing (CM (+D)) PC3 cells. A representative image of the crystal violet staining is included below the quantifications. C Schematic representation of the experimental approach for production and combination of conditioned medias. D Dose-dependent effect of PGC1α-expressing PC3 cells´ conditioned media (CM (+D)). Different percentages of PGC1α-expressing and non-expressing PC3 conditioned media were used to grow and monitor 2D cell proliferation of recipient PC3 cells for 7 days (n = 3). E . Quantification of proliferation rate of PC3 TRIPZ cells co-cultured with PGC1α-expressing PC3 cells for 7 and 12 (7 + 5) days ( n = 3). In B , D , E , data are normalized to the -Dox (non-PGC1α expressing) conditions, depicted by a black dotted line. R: recipient cells. CM conditioned media, D or Dox doxycycline, FC fold change. Statistics: one sample t-test with reference value 1 ( B , D ), ordinary one-way ANOVA ( D , depicted with a dollar symbol). * p .value < 0.05; ** p .value < 0.01; ***/$$$ p .value < 0.001. Error bars indicate s.e.m.

    Article Snippet: The following antibodies were used: PGC1α H300 (Santa Cruz Biotechnology #sc-13067), ERRα (Cell Signaling Technology#13826), β-actin (Cell SignalingTechnology #3700S, RRID:AB_2242334), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), SRM (Proteintech #19858-1-AP), CD9 (R and D Systems Cat# MAB1880, RRID:AB_2075900), CD63 (DSHB Cat# h5c6, RRID:AB_528158), GRP78 (BD Biosciences 40/BiP), COX IV (Cell Signaling Technology Cat# 11967, RRID:AB_2797784).

    Techniques: Produced, Expressing, Staining, Cell Culture

    A Quantification of 2D-cell proliferation (crystal violet) of PC3 ( n = 3) grown with differential conditioned media produced by PGC1α non-expressing and expressing PC3 cells with or without deletion of ERRα. A representative image of the crystal violet staining is included the quantifications. B Quantification of 2D-cell proliferation (crystal violet) of PC3 ( n = 3) grown with the heavy fraction of conditioned media (>10 kDa) produced by PGC1α non-expressing and expressing PC3 cells with or without deletion of ERRα. C Effect of EVs produced by PGC1α non-expressing and expressing PC3 cells on the 2D-cell proliferation (crystal violet) of PC3 cells during 5 (left panel, n = 4) and 7 days (right panel, n = 5). D Effect of EVs-depleted fraction produced by PGC1α non-expressing and expressing PC3 cells on the 2D-cell proliferation (crystal violet) of PC3 cells during 5 (left panel, n = 4) and 7 days (right panel, n = 4). All data are normalized to the CM - Dox (non-PGC1α expressing) condition, depicted by a black dotted line. R: recipient cells. CM conditioned media. SFs soluble factors, EVs extracellular vesicles. D or Dox: doxycyline. Statistics: one sample t -test with reference value 1 ( A – D ); paired- t -test ( A , B ). */$ p .value 0.05; **/$$ p .value < 0.01; ***/$$$ p .value 0.001. Asterisks indicate statistical difference between No Dox and Dox conditions and dollar symbols indicate statistical difference between Control Dox and sgERRα#1/sgERRα#2 Dox. Error bars indicate s.e.m.

    Journal: Cell Death & Disease

    Article Title: Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer

    doi: 10.1038/s41419-025-07639-4

    Figure Lengend Snippet: A Quantification of 2D-cell proliferation (crystal violet) of PC3 ( n = 3) grown with differential conditioned media produced by PGC1α non-expressing and expressing PC3 cells with or without deletion of ERRα. A representative image of the crystal violet staining is included the quantifications. B Quantification of 2D-cell proliferation (crystal violet) of PC3 ( n = 3) grown with the heavy fraction of conditioned media (>10 kDa) produced by PGC1α non-expressing and expressing PC3 cells with or without deletion of ERRα. C Effect of EVs produced by PGC1α non-expressing and expressing PC3 cells on the 2D-cell proliferation (crystal violet) of PC3 cells during 5 (left panel, n = 4) and 7 days (right panel, n = 5). D Effect of EVs-depleted fraction produced by PGC1α non-expressing and expressing PC3 cells on the 2D-cell proliferation (crystal violet) of PC3 cells during 5 (left panel, n = 4) and 7 days (right panel, n = 4). All data are normalized to the CM - Dox (non-PGC1α expressing) condition, depicted by a black dotted line. R: recipient cells. CM conditioned media. SFs soluble factors, EVs extracellular vesicles. D or Dox: doxycyline. Statistics: one sample t -test with reference value 1 ( A – D ); paired- t -test ( A , B ). */$ p .value 0.05; **/$$ p .value < 0.01; ***/$$$ p .value 0.001. Asterisks indicate statistical difference between No Dox and Dox conditions and dollar symbols indicate statistical difference between Control Dox and sgERRα#1/sgERRα#2 Dox. Error bars indicate s.e.m.

    Article Snippet: The following antibodies were used: PGC1α H300 (Santa Cruz Biotechnology #sc-13067), ERRα (Cell Signaling Technology#13826), β-actin (Cell SignalingTechnology #3700S, RRID:AB_2242334), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), SRM (Proteintech #19858-1-AP), CD9 (R and D Systems Cat# MAB1880, RRID:AB_2075900), CD63 (DSHB Cat# h5c6, RRID:AB_528158), GRP78 (BD Biosciences 40/BiP), COX IV (Cell Signaling Technology Cat# 11967, RRID:AB_2797784).

    Techniques: Produced, Expressing, Staining, Control

    A Volcano plot representing label-free LC/MS data of proteins differentially secreted by PGC1α expressing and non-expressing PC3 cells. B Volcano plot representing label-free LC/MS data of proteins differentially detected in the tumor interstitial liquid (TIL) isolated from Pten and Pten/Pgc1a KO prostate tumors. C Venn Diagram (left panel) showing the common secreted proteins differentially detected by LC/MS in vitro (CM) and in vivo (TIL) and histogram (right panel) showing the degree of change in the detection of SRM. Effect of PGC1α re-expression on SRM in PC3 cells ( D , RT-qPCR, n = 3; E one representative Western blot out of 4, quantifications are shown below). F Effect of ERRα deletion on the PGC1α-driven transcriptional deregulation of SRM (RT-qPCR, n = 3). G Chromatin immunoprecipitation of exogenous PGC1α on SRM promoter in PC3-PGC1α expressing cells after induction with 0.5 mg/mL doxycycline ( n = 3). Final data were normalized to IgG (negative immunoprecipitation control). CM conditioned media, D or Dox: doxycycline, FC fold change. Statistics: one sample t -test with reference value 1 ( D , F , G ); paired- t -test ( F ). */$ p .value 0.05; **/$$ p .value < 0.01; ***/$$$ p .value < 0.001. Asterisks indicate statistical difference between No Dox and Dox conditions and dollar symbols indicate statistical difference between Control Dox and sgERRα#1/sgERRα#2 Dox. Error bars indicate s.e.m.

    Journal: Cell Death & Disease

    Article Title: Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer

    doi: 10.1038/s41419-025-07639-4

    Figure Lengend Snippet: A Volcano plot representing label-free LC/MS data of proteins differentially secreted by PGC1α expressing and non-expressing PC3 cells. B Volcano plot representing label-free LC/MS data of proteins differentially detected in the tumor interstitial liquid (TIL) isolated from Pten and Pten/Pgc1a KO prostate tumors. C Venn Diagram (left panel) showing the common secreted proteins differentially detected by LC/MS in vitro (CM) and in vivo (TIL) and histogram (right panel) showing the degree of change in the detection of SRM. Effect of PGC1α re-expression on SRM in PC3 cells ( D , RT-qPCR, n = 3; E one representative Western blot out of 4, quantifications are shown below). F Effect of ERRα deletion on the PGC1α-driven transcriptional deregulation of SRM (RT-qPCR, n = 3). G Chromatin immunoprecipitation of exogenous PGC1α on SRM promoter in PC3-PGC1α expressing cells after induction with 0.5 mg/mL doxycycline ( n = 3). Final data were normalized to IgG (negative immunoprecipitation control). CM conditioned media, D or Dox: doxycycline, FC fold change. Statistics: one sample t -test with reference value 1 ( D , F , G ); paired- t -test ( F ). */$ p .value 0.05; **/$$ p .value < 0.01; ***/$$$ p .value < 0.001. Asterisks indicate statistical difference between No Dox and Dox conditions and dollar symbols indicate statistical difference between Control Dox and sgERRα#1/sgERRα#2 Dox. Error bars indicate s.e.m.

    Article Snippet: The following antibodies were used: PGC1α H300 (Santa Cruz Biotechnology #sc-13067), ERRα (Cell Signaling Technology#13826), β-actin (Cell SignalingTechnology #3700S, RRID:AB_2242334), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), SRM (Proteintech #19858-1-AP), CD9 (R and D Systems Cat# MAB1880, RRID:AB_2075900), CD63 (DSHB Cat# h5c6, RRID:AB_528158), GRP78 (BD Biosciences 40/BiP), COX IV (Cell Signaling Technology Cat# 11967, RRID:AB_2797784).

    Techniques: Liquid Chromatography with Mass Spectroscopy, Expressing, Isolation, In Vitro, In Vivo, Quantitative RT-PCR, Western Blot, Chromatin Immunoprecipitation, Immunoprecipitation, Control

    A Incorporation of 13 C from U-13C5-L-Methionine (2 h pulse) into spermidine and spermine metabolites after 3 day-treatment of PC3 cells grown with the indicated CM. B Validation of SRM overexpression in PC3 cells with inducible expression of PGC1α (Western blot, one representative image out of 4). C Quantification of 2D-cell proliferation (crystal violet) of PC3 grown with differential CM produced by: PGC1α non-expressing and expressing PC3 cells with or without overexpression of SRM ( n = 4). D Quantification of PC3-luc cells co-injected in nude mice together with PGC1α non-expressing (No Dox) and expressing (Dox) PC3 cells with or without overexpression of SRM, at day 6 (left panel) and 16 (right panel). ( n = 10 tumors per group; 2 injections per mice). E Confirmation of SRM silencing in PC3 cells using two independent short hairpin RNAs (Western blot, one representative image out of 3). F Quantification of 2D-cell proliferation (crystal violet) of PC3 grown with differential CM produced by PC3 cells in which the expression of SRM was silenced ( n = 3). In C , E , a representative image of the crystal violet staining is included beside and below the quantification, respectively. In C , F , data are normalized to the CM -Dox (non-PGC1α expressing) condition ( C ) or to the CM shScr ( F ), depicted by a black dotted line. P producer cells, R recipient cells, CM conditioned media, D or Dox doxycycline, FC fold change. n.s not significant. Statistics: one sample t -test with reference value 1 ( C , F ), unpaired- t -test ( A , C ), Mann Whitney test ( D ). Asterisks and dollar symbols indicate statistical differences between the experimental groups. */$ p .value < 0.05; ** p .value < 0.01; *** p .value < 0.001. Error bars indicate s.e.m.

    Journal: Cell Death & Disease

    Article Title: Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer

    doi: 10.1038/s41419-025-07639-4

    Figure Lengend Snippet: A Incorporation of 13 C from U-13C5-L-Methionine (2 h pulse) into spermidine and spermine metabolites after 3 day-treatment of PC3 cells grown with the indicated CM. B Validation of SRM overexpression in PC3 cells with inducible expression of PGC1α (Western blot, one representative image out of 4). C Quantification of 2D-cell proliferation (crystal violet) of PC3 grown with differential CM produced by: PGC1α non-expressing and expressing PC3 cells with or without overexpression of SRM ( n = 4). D Quantification of PC3-luc cells co-injected in nude mice together with PGC1α non-expressing (No Dox) and expressing (Dox) PC3 cells with or without overexpression of SRM, at day 6 (left panel) and 16 (right panel). ( n = 10 tumors per group; 2 injections per mice). E Confirmation of SRM silencing in PC3 cells using two independent short hairpin RNAs (Western blot, one representative image out of 3). F Quantification of 2D-cell proliferation (crystal violet) of PC3 grown with differential CM produced by PC3 cells in which the expression of SRM was silenced ( n = 3). In C , E , a representative image of the crystal violet staining is included beside and below the quantification, respectively. In C , F , data are normalized to the CM -Dox (non-PGC1α expressing) condition ( C ) or to the CM shScr ( F ), depicted by a black dotted line. P producer cells, R recipient cells, CM conditioned media, D or Dox doxycycline, FC fold change. n.s not significant. Statistics: one sample t -test with reference value 1 ( C , F ), unpaired- t -test ( A , C ), Mann Whitney test ( D ). Asterisks and dollar symbols indicate statistical differences between the experimental groups. */$ p .value < 0.05; ** p .value < 0.01; *** p .value < 0.001. Error bars indicate s.e.m.

    Article Snippet: The following antibodies were used: PGC1α H300 (Santa Cruz Biotechnology #sc-13067), ERRα (Cell Signaling Technology#13826), β-actin (Cell SignalingTechnology #3700S, RRID:AB_2242334), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), SRM (Proteintech #19858-1-AP), CD9 (R and D Systems Cat# MAB1880, RRID:AB_2075900), CD63 (DSHB Cat# h5c6, RRID:AB_528158), GRP78 (BD Biosciences 40/BiP), COX IV (Cell Signaling Technology Cat# 11967, RRID:AB_2797784).

    Techniques: Biomarker Discovery, Over Expression, Expressing, Western Blot, Produced, Injection, Staining, MANN-WHITNEY

    A Analysis of SRM mRNA in PCa patients stratified according to the mean expression of PGC1α mRNA (PPARGC1A). B Correlation analysis between PPARGC1A and SRM mRNA expression in primary tumor specimens of different prostate cancer datasets. C Association of the combined expression of PPARGC1A and SRM mRNA with disease-free survival (DFS) in human PCa specimens. Patients were grouped according to the average mRNA expression of both genes. H: high, above average. L: low, below average. Four groups were generated: PGC1α H - SRM L, PGC1α L - SRM H, PGC1α H - SRM H and PGC1α L - SRM L. Sample sizes: Grasso, n = 45; Taylor, n = 131; Glinsky, n = 79 and TCGA provisional, n = 497. Statistics: Mann Whitney test ( A ) Spearman correlation Rho/ρ ( B ), Log-rank (Mantel–Cox) test ( C ). * p .value < 0.05; ** p .value < 0.01; *** p .value < 0.001. Error bars indicate s.e.m. HR harzard ratio, p.v p -value.

    Journal: Cell Death & Disease

    Article Title: Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer

    doi: 10.1038/s41419-025-07639-4

    Figure Lengend Snippet: A Analysis of SRM mRNA in PCa patients stratified according to the mean expression of PGC1α mRNA (PPARGC1A). B Correlation analysis between PPARGC1A and SRM mRNA expression in primary tumor specimens of different prostate cancer datasets. C Association of the combined expression of PPARGC1A and SRM mRNA with disease-free survival (DFS) in human PCa specimens. Patients were grouped according to the average mRNA expression of both genes. H: high, above average. L: low, below average. Four groups were generated: PGC1α H - SRM L, PGC1α L - SRM H, PGC1α H - SRM H and PGC1α L - SRM L. Sample sizes: Grasso, n = 45; Taylor, n = 131; Glinsky, n = 79 and TCGA provisional, n = 497. Statistics: Mann Whitney test ( A ) Spearman correlation Rho/ρ ( B ), Log-rank (Mantel–Cox) test ( C ). * p .value < 0.05; ** p .value < 0.01; *** p .value < 0.001. Error bars indicate s.e.m. HR harzard ratio, p.v p -value.

    Article Snippet: The following antibodies were used: PGC1α H300 (Santa Cruz Biotechnology #sc-13067), ERRα (Cell Signaling Technology#13826), β-actin (Cell SignalingTechnology #3700S, RRID:AB_2242334), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), SRM (Proteintech #19858-1-AP), CD9 (R and D Systems Cat# MAB1880, RRID:AB_2075900), CD63 (DSHB Cat# h5c6, RRID:AB_528158), GRP78 (BD Biosciences 40/BiP), COX IV (Cell Signaling Technology Cat# 11967, RRID:AB_2797784).

    Techniques: Expressing, Generated, MANN-WHITNEY

    Fig. 2. MutSβ deficiency induces R-loop-dependent replication stress. (A to F) MSH3 depletion induces replication fork stalling and micronucleation in U2OS cells. (A) Top: Workflow of DNA fiber assays. Bottom: Representative images of replication tracts on DNA fibers of cells transfected with indicated siRNAs. (B) Quantification of the lengths of replication tracts (CldU + IdU) in the images represented in (A) (n ≥ 311). (C) Representative images of symmetric and asymmetric replication tracts of sister forks observed on DNA fiber spreads in (A). (D) Plot of the values of IdU tract length ratio of sister forks (sister fork ratio) obtained for indicated conditions (n ≥ 120). (E) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Representative images of binucleated cells with or without micronucleus (red arrow). (F) Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). (G to K) RNase H1 overexpression rescues replication fork stalling and micronucleation in MSH3-depleted cells. (G) Western blot analysis of extracts of U2OS T-REx [RNH1-GFP] cells transfected with indicated siRNAs and treated with (+) or without (−) doxycycline (Dox; 1 ng/ml) to induce expression of GFP-tagged RNase H1 (RNH1-GFP). (H) Workflow of DNA fiber assays. (I) Quantification of the lengths of DNA replication tracts for indicated conditions (n ≥ 402). (J) Plot of the values of sister fork ratio obtained for indicated conditions (n ≥ 211). (K) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (B), (D), (I), and (J). ****P < 0.0001. One-way ANOVA with Tukey’s mul- tiple comparisons correction was used in (F) and (K). ***P < 0.001 and *P < 0.05. All DNA fiber experiments were performed three times. Red lines represent median val- ues. Scale bars, 10 μm. ns, not significant.

    Journal: Science advances

    Article Title: MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops.

    doi: 10.1126/sciadv.adk2685

    Figure Lengend Snippet: Fig. 2. MutSβ deficiency induces R-loop-dependent replication stress. (A to F) MSH3 depletion induces replication fork stalling and micronucleation in U2OS cells. (A) Top: Workflow of DNA fiber assays. Bottom: Representative images of replication tracts on DNA fibers of cells transfected with indicated siRNAs. (B) Quantification of the lengths of replication tracts (CldU + IdU) in the images represented in (A) (n ≥ 311). (C) Representative images of symmetric and asymmetric replication tracts of sister forks observed on DNA fiber spreads in (A). (D) Plot of the values of IdU tract length ratio of sister forks (sister fork ratio) obtained for indicated conditions (n ≥ 120). (E) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Representative images of binucleated cells with or without micronucleus (red arrow). (F) Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). (G to K) RNase H1 overexpression rescues replication fork stalling and micronucleation in MSH3-depleted cells. (G) Western blot analysis of extracts of U2OS T-REx [RNH1-GFP] cells transfected with indicated siRNAs and treated with (+) or without (−) doxycycline (Dox; 1 ng/ml) to induce expression of GFP-tagged RNase H1 (RNH1-GFP). (H) Workflow of DNA fiber assays. (I) Quantification of the lengths of DNA replication tracts for indicated conditions (n ≥ 402). (J) Plot of the values of sister fork ratio obtained for indicated conditions (n ≥ 211). (K) Top: Workflow of cytokinesis-block micronucleus assay. Bottom: Quantification of the percentage of micronucleus-positive binucleated cells for indicated conditions. Data are means ± SEM (n = 3). Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (B), (D), (I), and (J). ****P < 0.0001. One-way ANOVA with Tukey’s mul- tiple comparisons correction was used in (F) and (K). ***P < 0.001 and *P < 0.05. All DNA fiber experiments were performed three times. Red lines represent median val- ues. Scale bars, 10 μm. ns, not significant.

    Article Snippet: The following primary antibodies were used for immunoblotting: GFP rabbit polyclonal (1:2000; ab290, Abcam), MSH3 (H300) rabbit polyclonal (1:1000; sc11441, Santa Cruz Biotechnology), MSH6 (clone 44/MSH6) mouse monoclonal (1:1000; 610918, BD Transduction Laboratories), PMS1 (E- 3) mouse monoclonal (1:1000; sc- 515302, Santa Cruz Biotechnology), PMS2 (clone A16- 4) mouse monoclonal (1:1000; 556415, BD Pharmingen), BRIP1/FANCJ rabbit polyclonal (1:1000; NBP1- 31883, Novus Biologicals), TFIIH p89 (S- 19) rabbit polyclonal (1:1000; sc293, Santa Cruz Biotechnology), glyceraldehyde- 3- phosphate dehydrogenase (0411) mouse monoclonal (1:1000; sc- 47724, Santa Cruz Biotechnology), β tubulin (clone TUB 2.1) mouse monoclonal (1:1000; T- 4026, Sigma- Aldrich), and γ- tubulin rabbit polyclonal (1:1000; T- 3559, Sigma- Aldrich).

    Techniques: Transfection, Blocking Assay, Over Expression, Western Blot, Expressing

    Fig. 3. MutSβ is required for replication restart at R-loop–stalled replication forks. (A) Top: Workflow of DNA fiber assays with U2OS cells. The PARP inhibitor olaparib [10 μM; PARP inhibition (PARPi)/Pi] was added 2 hours before replication tract labeling and was also present during the labeling. PDS (10 μM) or CPT (100 nM) were added together with IdU. Bottom: Representative images of DNA replication tracts of U2OS cells transfected with control siRNA (siLuc) and treated as indicated. Scale bar, 10 μm. (B) Effect of depletion of MSH3 or MSH6 on replication fork progression in U2OS cells treated as indicated. Scatter plot of the IdU/CldU tract length ratio is shown. At least 328 replication tracts were scored in three independent experiments for each condition. Red lines represent median values. ****P < 0.0001 (Kruskal-Wallis test followed by Dunn’s multiple comparisons test). ns, not significant.

    Journal: Science advances

    Article Title: MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops.

    doi: 10.1126/sciadv.adk2685

    Figure Lengend Snippet: Fig. 3. MutSβ is required for replication restart at R-loop–stalled replication forks. (A) Top: Workflow of DNA fiber assays with U2OS cells. The PARP inhibitor olaparib [10 μM; PARP inhibition (PARPi)/Pi] was added 2 hours before replication tract labeling and was also present during the labeling. PDS (10 μM) or CPT (100 nM) were added together with IdU. Bottom: Representative images of DNA replication tracts of U2OS cells transfected with control siRNA (siLuc) and treated as indicated. Scale bar, 10 μm. (B) Effect of depletion of MSH3 or MSH6 on replication fork progression in U2OS cells treated as indicated. Scatter plot of the IdU/CldU tract length ratio is shown. At least 328 replication tracts were scored in three independent experiments for each condition. Red lines represent median values. ****P < 0.0001 (Kruskal-Wallis test followed by Dunn’s multiple comparisons test). ns, not significant.

    Article Snippet: The following primary antibodies were used for immunoblotting: GFP rabbit polyclonal (1:2000; ab290, Abcam), MSH3 (H300) rabbit polyclonal (1:1000; sc11441, Santa Cruz Biotechnology), MSH6 (clone 44/MSH6) mouse monoclonal (1:1000; 610918, BD Transduction Laboratories), PMS1 (E- 3) mouse monoclonal (1:1000; sc- 515302, Santa Cruz Biotechnology), PMS2 (clone A16- 4) mouse monoclonal (1:1000; 556415, BD Pharmingen), BRIP1/FANCJ rabbit polyclonal (1:1000; NBP1- 31883, Novus Biologicals), TFIIH p89 (S- 19) rabbit polyclonal (1:1000; sc293, Santa Cruz Biotechnology), glyceraldehyde- 3- phosphate dehydrogenase (0411) mouse monoclonal (1:1000; sc- 47724, Santa Cruz Biotechnology), β tubulin (clone TUB 2.1) mouse monoclonal (1:1000; T- 4026, Sigma- Aldrich), and γ- tubulin rabbit polyclonal (1:1000; T- 3559, Sigma- Aldrich).

    Techniques: Inhibition, Labeling, Transfection, Control

    Fig. 5. MutSβ mediates replication restart at R-loop–stalled replication forks through its G4-binding activity. (A to E) Y245S/K246E substitutions in MSH3 induce replication fork stalling and micronucleation. (A) Western blot analysis of expression of WT or Y245S/K246E variants of GFP-tagged MSH3 in U2OS T-REx cells. Cells were transfected with indicated siRNAs for 72 hours and treated with doxycycline (0.4 ng/ml) in the past 24 hours or left untreated to induce transgene expression. (B) Experi- mental workflow of DNA fiber assays with cells in (A). (C) Quantification of replication tract lengths (CldU + IdU) for indicated conditions from three independent experi- ments (n ≥ 325). Horizontal lines represent median values. (D) Plot of the values of IdU tract length ratio of sister forks (sister fork ratio) obtained for indicated conditions (n ≥ 133). Horizontal lines represent median values. (E) Quantification of the frequency of micronuclei for indicated conditions. Data are means ± SEM (n = 3). (F) Y245S/ K246E substitutions in MSH3 abolish the rescue of PDS-induced fork slowing by PARPi. Top: Workflow of DNA fiber assays with cells in (A). PARPi treatment was carried out as in Fig. 3A. PDS (10 μM) was added together with IdU. Bottom: Scatter plot of the values of IdU/CldU tract length ratio obtained for indicated conditions in two indepen- dent experiments (n ≥ 251). Horizontal lines represent median values. Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (C), (D), and (F). ****P < 0.0001. One-way ANOVA with Tukey’s multiple comparisons correction was used in (E). ***P < 0.001, **P < 0.01, and *P < 0.05. ns, not significant.

    Journal: Science advances

    Article Title: MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops.

    doi: 10.1126/sciadv.adk2685

    Figure Lengend Snippet: Fig. 5. MutSβ mediates replication restart at R-loop–stalled replication forks through its G4-binding activity. (A to E) Y245S/K246E substitutions in MSH3 induce replication fork stalling and micronucleation. (A) Western blot analysis of expression of WT or Y245S/K246E variants of GFP-tagged MSH3 in U2OS T-REx cells. Cells were transfected with indicated siRNAs for 72 hours and treated with doxycycline (0.4 ng/ml) in the past 24 hours or left untreated to induce transgene expression. (B) Experi- mental workflow of DNA fiber assays with cells in (A). (C) Quantification of replication tract lengths (CldU + IdU) for indicated conditions from three independent experi- ments (n ≥ 325). Horizontal lines represent median values. (D) Plot of the values of IdU tract length ratio of sister forks (sister fork ratio) obtained for indicated conditions (n ≥ 133). Horizontal lines represent median values. (E) Quantification of the frequency of micronuclei for indicated conditions. Data are means ± SEM (n = 3). (F) Y245S/ K246E substitutions in MSH3 abolish the rescue of PDS-induced fork slowing by PARPi. Top: Workflow of DNA fiber assays with cells in (A). PARPi treatment was carried out as in Fig. 3A. PDS (10 μM) was added together with IdU. Bottom: Scatter plot of the values of IdU/CldU tract length ratio obtained for indicated conditions in two indepen- dent experiments (n ≥ 251). Horizontal lines represent median values. Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (C), (D), and (F). ****P < 0.0001. One-way ANOVA with Tukey’s multiple comparisons correction was used in (E). ***P < 0.001, **P < 0.01, and *P < 0.05. ns, not significant.

    Article Snippet: The following primary antibodies were used for immunoblotting: GFP rabbit polyclonal (1:2000; ab290, Abcam), MSH3 (H300) rabbit polyclonal (1:1000; sc11441, Santa Cruz Biotechnology), MSH6 (clone 44/MSH6) mouse monoclonal (1:1000; 610918, BD Transduction Laboratories), PMS1 (E- 3) mouse monoclonal (1:1000; sc- 515302, Santa Cruz Biotechnology), PMS2 (clone A16- 4) mouse monoclonal (1:1000; 556415, BD Pharmingen), BRIP1/FANCJ rabbit polyclonal (1:1000; NBP1- 31883, Novus Biologicals), TFIIH p89 (S- 19) rabbit polyclonal (1:1000; sc293, Santa Cruz Biotechnology), glyceraldehyde- 3- phosphate dehydrogenase (0411) mouse monoclonal (1:1000; sc- 47724, Santa Cruz Biotechnology), β tubulin (clone TUB 2.1) mouse monoclonal (1:1000; T- 4026, Sigma- Aldrich), and γ- tubulin rabbit polyclonal (1:1000; T- 3559, Sigma- Aldrich).

    Techniques: Binding Assay, Activity Assay, Western Blot, Expressing, Transfection

    Fig. 9. Reactivation of R-loop–stalled replication forks requires MLH1-FANCJ interaction. (A to D) Depletion of MSH3 or PMS1 impairs FANCJ recruitment to G4s in U2OS cells. (A) Representative images of FANCJ/BG4 PLA foci in EdU-positive nuclei. Where indicated, cells were treated with TRP (1 μM) for 2 hours. EdU was present the last 15 min. Scale bar, 10 μm. (B) Quantification of FANCJ/BG4 PLA foci in images represented in (A). (C) Quantification of FANCJ/BG4 PLA foci in U2OS cells lacking MSH3 or PMS1. A representative plot from two independent experiments is shown (n ≥ 1364). Images from PLA with BG4 or FANCJ antibody only were also analyzed. (D) Western blot analysis of extracts of cells in (C). (E and F) K141/142A substitutions in FANCJ abolish its recruitment to G4s in unchallenged cells. (E) Western blot analysis of extracts of FANCJ+/+ or FANCJ−/− HeLa FIT cells. Where indicated, the expression of WT or K141/142A variants of FANCJ was induced with doxycycline (1 μg/ml) in FANCJ−/− cells. (F) Quantification of FANCJ/BG4 PLA foci in cells in (E). A representative plot from two independent experiments is shown (n ≥ 420). (G) K141/142A substitutions in FANCJ induce replication fork stalling in unchallenged cells. Top: Experimental workflow of DNA fiber assays with cells in (E). Bottom: Plot of the values of sister fork ratio obtained for indicated conditions in two independent experiments (n ≥ 202). (H) K141/142A substitutions in FANCJ abolish the rescue of PDS-induced fork slowing by PARPi. Top: Workflow of DNA fiber assays with cells in (E). Bottom: Plot of the values of IdU/CldU tract length ratio obtained for indicated conditions in two independent experiments (n ≥ 189). Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (B), (C), and (F) to (H). ****P < 0.0001. Red lines represent median values. ns, not significant.

    Journal: Science advances

    Article Title: MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops.

    doi: 10.1126/sciadv.adk2685

    Figure Lengend Snippet: Fig. 9. Reactivation of R-loop–stalled replication forks requires MLH1-FANCJ interaction. (A to D) Depletion of MSH3 or PMS1 impairs FANCJ recruitment to G4s in U2OS cells. (A) Representative images of FANCJ/BG4 PLA foci in EdU-positive nuclei. Where indicated, cells were treated with TRP (1 μM) for 2 hours. EdU was present the last 15 min. Scale bar, 10 μm. (B) Quantification of FANCJ/BG4 PLA foci in images represented in (A). (C) Quantification of FANCJ/BG4 PLA foci in U2OS cells lacking MSH3 or PMS1. A representative plot from two independent experiments is shown (n ≥ 1364). Images from PLA with BG4 or FANCJ antibody only were also analyzed. (D) Western blot analysis of extracts of cells in (C). (E and F) K141/142A substitutions in FANCJ abolish its recruitment to G4s in unchallenged cells. (E) Western blot analysis of extracts of FANCJ+/+ or FANCJ−/− HeLa FIT cells. Where indicated, the expression of WT or K141/142A variants of FANCJ was induced with doxycycline (1 μg/ml) in FANCJ−/− cells. (F) Quantification of FANCJ/BG4 PLA foci in cells in (E). A representative plot from two independent experiments is shown (n ≥ 420). (G) K141/142A substitutions in FANCJ induce replication fork stalling in unchallenged cells. Top: Experimental workflow of DNA fiber assays with cells in (E). Bottom: Plot of the values of sister fork ratio obtained for indicated conditions in two independent experiments (n ≥ 202). (H) K141/142A substitutions in FANCJ abolish the rescue of PDS-induced fork slowing by PARPi. Top: Workflow of DNA fiber assays with cells in (E). Bottom: Plot of the values of IdU/CldU tract length ratio obtained for indicated conditions in two independent experiments (n ≥ 189). Kruskal-Wallis test followed by Dunn’s multiple comparisons test was used in (B), (C), and (F) to (H). ****P < 0.0001. Red lines represent median values. ns, not significant.

    Article Snippet: The following primary antibodies were used for immunoblotting: GFP rabbit polyclonal (1:2000; ab290, Abcam), MSH3 (H300) rabbit polyclonal (1:1000; sc11441, Santa Cruz Biotechnology), MSH6 (clone 44/MSH6) mouse monoclonal (1:1000; 610918, BD Transduction Laboratories), PMS1 (E- 3) mouse monoclonal (1:1000; sc- 515302, Santa Cruz Biotechnology), PMS2 (clone A16- 4) mouse monoclonal (1:1000; 556415, BD Pharmingen), BRIP1/FANCJ rabbit polyclonal (1:1000; NBP1- 31883, Novus Biologicals), TFIIH p89 (S- 19) rabbit polyclonal (1:1000; sc293, Santa Cruz Biotechnology), glyceraldehyde- 3- phosphate dehydrogenase (0411) mouse monoclonal (1:1000; sc- 47724, Santa Cruz Biotechnology), β tubulin (clone TUB 2.1) mouse monoclonal (1:1000; T- 4026, Sigma- Aldrich), and γ- tubulin rabbit polyclonal (1:1000; T- 3559, Sigma- Aldrich).

    Techniques: Western Blot, Expressing